1 | (11C)PE2I | - | - | - | - | 1件: 6 6 |
2 | (2-chloro-5-[11C]methoxy-N-(((3s,5s,7s)-3,5,7-trifluoroadamantan-1-yl)methyl) benzamide) | - | - | - | - | 1件: 6 6 |
3 | (3beta, 5beta, 25R)-spirostan-3-ol | - | - | - | - | 1件: 6 6 |
4 | (3ß, 5ß, 25R)-spirostan-3-ol | - | - | - | - | 1件: 6 6 |
5 | (6S)-6-{propyl-[2-[2-thienyl]ethyl]amino}-5,6,7,8-tetrahydro-1-naphtalenol | - | - | - | - | 1件: 6 6 |
6 | (minus)-L-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid monohydrate | - | - | - | - | 1件: 6 6 |
7 | (R)-troloxamide quinone | - | - | - | - | 1件: 6 6 |
8 | (S)- 2- Amino- 4,5,6,7- tetrahydro- 6- (propylamino)benzothiazol | - | - | - | - | 1件: 6 6 |
9 | (S)-(+)-2-(4-(3-fluorobenzyl)oxybenzyl)aminopropanamide methanesulfonate | - | - | - | - | 1件: 6 6 |
10 | 0 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: D00397
D00397
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
11 | 0.04 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
12 | 0.08 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
13 | 0.2 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
14 | 0.3 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: D00397
D00397
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
15 | 0.4 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
16 | 0.6 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
17 | 0.8 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
18 | 0.9% saline | - | - | - | - | 2件: 6 6, 70 |
19 | 0.9% sodium chloride | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 4件: 6 6, 14, 51, 53 |
20 | 0.9% sodium chloride (normal saline) | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 1件: 6 6 |
21 | 00000 | - | - | - | - | 2件: 6 6, 96 |
22 | 000000 | - | - | - | - | 1件: 6 6 |
23 | 009-0 | - | - | - | - | 1件: 6 6 |
24 | 009-1 | - | - | - | - | 1件: 6 6 |
25 | 009-2 | - | - | - | - | 1件: 6 6 |
26 | 009-3 | - | - | - | - | 1件: 6 6 |
27 | 009-4 | - | - | - | - | 1件: 6 6 |
28 | 009-5 | - | - | - | - | 1件: 6 6 |
29 | 009-A0 | - | - | - | - | 1件: 6 6 |
30 | 009-A1 | - | - | - | - | 1件: 6 6 |
31 | 009-A2 | - | - | - | - | 1件: 6 6 |
32 | 009-A3 | - | - | - | - | 1件: 6 6 |
33 | 023145028 | - | - | - | - | 1件: 6 6 |
34 | 043906039 | - | - | - | - | 1件: 6 6 |
35 | 1 mg QD to 15 mg QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
36 | 1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
37 | 1 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: D00397
D00397
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
38 | 1. Tesofensine (NS 2330) | 1件: Tesofensine Tesofensine | - | - | - | 1件: 6 6 |
39 | 1.0 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
40 | 1.0 mg rasagiline mesylate | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
41 | 1.2 mg Lu AE04621 | - | - | - | - | 1件: 6 6 |
42 | 100 | - | - | - | - | 2件: 6 6, 97 |
43 | 11C-PBR28 | - | - | - | - | 2件: 6 6, 13 |
44 | 11C-PiB | - | - | - | - | 2件: 6 6, 13 |
45 | 11C-Raclopride | 1件: Raclopride Raclopride | - | - | - | 1件: 6 6 |
46 | 11C]PBR28 | - | - | - | - | 1件: 6 6 |
47 | 11C]SMW139 | - | - | - | - | 1件: 6 6 |
48 | 125 | - | - | - | - | 1件: 6 6 |
49 | 15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
50 | 15 mg QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
51 | 15O H2O | - | - | - | - | 1件: 6 6 |
52 | 15O]H2O | - | - | - | - | 1件: 6 6 |
53 | 18-FDTBZ | - | - | - | - | 1件: 6 6 |
54 | 18F florbetaben | 1件: Florbetaben (18F) Florbetaben (18F) | - | - | - | 1件: 6 6 |
55 | 18F- DTBZ | - | - | - | - | 1件: 6 6 |
56 | 18F-AV-133 | 1件: Florbenazine F-18 Florbenazine F-18 | - | - | - | 1件: 6 6 |
57 | 18F-AV-45 | - | - | - | - | 2件: 6 6, 127 |
58 | 18F-DOPA | - | - | - | - | 2件: 6 6, 75 |
59 | 18F-DOPA PET | - | - | - | - | 1件: 6 6 |
60 | 18F-DTBZ | - | - | - | - | 1件: 6 6 |
61 | 18F-DTBZ AV-133 | - | - | - | - | 1件: 6 6 |
62 | 18F-FDG | 1件: Fludeoxyglucose (18F) Fludeoxyglucose (18F) | - | - | - | 13件: 5 5, 6, 7, 8, 13, 41, 46, 53, 84, 85, 96, 127, 300 |
63 | 18F] LBT-999 | - | - | - | - | 1件: 6 6 |
64 | 18F]-(E)-N-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane | - | - | - | - | 1件: 6 6 |
65 | 18F]FE-PE2I | - | - | - | - | 1件: 6 6 |
66 | 18F]MC225 | - | - | - | - | 1件: 6 6 |
67 | 1[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- | - | - | - | - | 1件: 6 6 |
68 | 1[(6- Allyl- 8beta- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea | - | - | - | - | 1件: 6 6 |
69 | 1[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- | - | - | - | - | 1件: 6 6 |
70 | 1[(6- Allyl- 8ß- ergolinyl)carbonyl]- 1- [3- (dimethylamino)propyl]- 3- ethylurea | - | - | - | - | 1件: 6 6 |
71 | 2 mg perampanel | 1件: Perampanel Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 6 6 |
72 | 2,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine-1-oxide | - | - | - | - | 1件: 6 6 |
73 | 2-[[[(2R)-1-[1-[(4-CHLORO-3-METHYLPHENYL)METHYL]-4- PIPERIDINYL]-5-OXO-2-PYRROLIDINYL]CARBONYL]AMINO]- N,N,6-TRIMETHYL-4-PYRIDINECARBOXAMIDE,DIHYDROCHLORIDE | - | - | - | - | 2件: 6 6, 162 |
74 | 200 mg BIA 6-512 | 1件: BIA BIA | - | - | - | 1件: 6 6 |
75 | 207-3120 | - | - | - | - | 1件: 6 6 |
76 | 240mg Amantadine HCl ER tablets | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
77 | 25 mg BIA9 1067 | - | - | - | - | 1件: 6 6 |
78 | 25 mg Ongentys | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
79 | 25330 | - | - | - | - | 1件: 6 6 |
80 | 3 mg QD to 15 mg QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
81 | 3 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
82 | 3 mg tropicamide | 1件: Tropicamide Tropicamide | 1件: D00397
D00397
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
83 | 3- (9,10- Didehydro- 6- methyl- 8?- ergolinyl)-1,1- diethylurea hydrogenmaleate | - | - | - | - | 1件: 6 6 |
84 | 3-(3,4-Dihydroxyphenyl)-L-alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 1件: 6 6 |
85 | 320mg Amantadine HCl ER tablets | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
86 | 4 mg perampanel | 1件: Perampanel Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 1件: 6 6 |
87 | 50 mg BIA 9 1067 | 1件: BIA BIA | - | - | - | 1件: 6 6 |
88 | 50 mg Ongentys | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
89 | 6036937.00.01 | - | - | - | - | 1件: 6 6 |
90 | 6abeta - apomorphine-10,11-diol hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
91 | 6aß - apomorphine-10,11-diol hydrochloride hemihydrate | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
92 | 7 mg QD to 15 mg QD PF-06649751 | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
93 | 7 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
94 | 7-beta-Hydroxyepiandrosterone | 1件: 7-beta-Hydroxyepiandrosterone 7-beta-Hydroxyepiandrosterone | - | - | - | 1件: 6 6 |
95 | 75 | - | - | - | - | 1件: 6 6 |
96 | 8-OHdG | 1件: 8-hydroxy-2'-deoxyguanosine 8-hydroxy-2'-deoxyguanosine | - | - | - | 1件: 6 6 |
97 | [11C]-PIB | - | - | - | - | 1件: 6 6 |
98 | [11C]PXT012253 | - | - | - | - | 1件: 6 6 |
99 | [123I] 5-IA | - | - | - | - | 1件: 6 6 |
100 | [123I] IBVM and SPECT imaging | - | - | - | - | 1件: 6 6 |
101 | [123I] mZINT injection and serial dynamic SPECT imaging | - | - | - | - | 1件: 6 6 |
102 | [123I]-IBVM | - | - | - | - | 1件: 6 6 |
103 | [123I]-IBZM imaging | - | - | - | - | 1件: 6 6 |
104 | [123I]B-CIT | - | - | - | - | 1件: 6 6 |
105 | [123I]B-CIT SPECT imaging | - | - | - | - | 1件: 6 6 |
106 | [123I]beta CIT | - | - | - | - | 1件: 6 6 |
107 | [123I]beta CIT and SPECT imaging | - | - | - | - | 1件: 6 6 |
108 | [123I]beta-CIT | - | - | - | - | 1件: 6 6 |
109 | [123I]beta-CIT and SPECT imaging | - | - | - | - | 1件: 6 6 |
110 | [123I]CLINDE | - | - | - | - | 2件: 6 6, 13 |
111 | [123I]MNI-420 | - | - | - | - | 2件: 6 6, 8 |
112 | [123I]ß CIT | - | - | - | - | 1件: 6 6 |
113 | [123I]ß CIT and SPECT imaging | - | - | - | - | 1件: 6 6 |
114 | [123I]ß-CIT | - | - | - | - | 1件: 6 6 |
115 | [123I]ß-CIT and SPECT imaging | - | - | - | - | 1件: 6 6 |
116 | [14C]-BIA 9-1067 | 1件: BIA BIA | - | - | - | 1件: 6 6 |
117 | [18F] CFPyPB | - | - | - | - | 1件: 6 6 |
118 | [18F] LBT-999 PET | - | - | - | - | 1件: 6 6 |
119 | [18F] PBR06 | - | - | - | - | 2件: 6 6, 13 |
120 | [18F] PI-2620 | - | - | - | - | 1件: 6 6 |
121 | [18F]-FEPPA | - | - | - | - | 2件: 6 6, 13 |
122 | [18F]DPA-714 PET scan | - | - | - | - | 1件: 6 6 |
123 | [18F]FDOPA | - | - | - | - | 2件: 6 6, 17 |
124 | [18F]FDOPA PET/CT | - | - | - | - | 1件: 6 6 |
125 | [18F]FPEB | - | - | - | - | 3件: 6 6, 8, 206 |
126 | [18F]MK-9470 | - | - | - | - | 1件: 6 6 |
127 | [18F]MNI-1126 | - | - | - | - | 1件: 6 6 |
128 | [18F]MNI-444 | - | - | - | - | 1件: 6 6 |
129 | [18F]MPPF | - | - | - | - | 1件: 6 6 |
130 | [18F]NOS | - | - | - | - | 1件: 6 6 |
131 | [18F]P17-059 | - | - | - | - | 1件: 6 6 |
132 | [18F]PI-2620 | - | - | - | - | 2件: 6 6, 127 |
133 | [18F]T807 ([18F]MNI-777) | - | - | - | - | 2件: 5 5, 6 |
134 | [18F]UCB-2897 | - | - | - | - | 1件: 6 6 |
135 | [21CFR640.30] Plasma from 18 - 25 year old volunteer donors | - | - | - | - | 1件: 6 6 |
136 | [F-18] Fluorodopa Positron Emission Tomography | - | - | - | - | 1件: 6 6 |
137 | A-dopamine | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
138 | Aadipose-Derived Mesenchymal Stem Cells | - | - | - | - | 1件: 6 6 |
139 | AAV2-GDNF | - | - | - | - | 1件: 6 6 |
140 | AB1010 | - | - | - | - | 6件: 2 2, 5, 6, 13, 46, 96 |
141 | ABBV-0805 | - | - | - | - | 1件: 6 6 |
142 | ABBV-951 | - | - | - | - | 1件: 6 6 |
143 | Abdominal compression | - | - | - | - | 2件: 6 6, 17 |
144 | ABT-SLV187 | - | - | - | - | 1件: 6 6 |
145 | Acamprosate | 1件: Acamprosate Acamprosate | 2件: D02780
D02780
,
D07058
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 2件: 6 6, 206 |
146 | Accordion Pill Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
147 | Accordion Pill ¿ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
148 | Accordion Pill ¿ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
149 | Accordion Pill? Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
150 | Accordion Pill? Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
151 | Accordion Pill¿ Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
152 | Accordion Pill™ Carbidopa/Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
153 | Accordion Pill™ Carbidopa/Levodopa 50/400 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
154 | Accordion Pill™ Carbidopa/Levodopa 50/500 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
155 | Acetate | 1件: Acetate Acetate | - | - | - | 43件: 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
156 | Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 20件: 6 6, 13, 19, 20, 34, 49, 51, 53, 58, 85, 90, 94, 111, 164, 193, 233, 296, 298, 299, 337 |
157 | ACP-103 | - | - | - | - | 1件: 6 6 |
158 | ACR325 | 1件: ACR325 ACR325 | - | - | - | 1件: 6 6 |
159 | ActiMyo recording | - | - | - | - | 1件: 6 6 |
160 | Active comparator | - | - | - | - | 2件: 6 6, 46 |
161 | Active drug (BIIB014) at 10, 30, 100, or 300 mg once daily. | - | - | - | - | 1件: 6 6 |
162 | Active drug: pimavanserin 17mg (2 strength tablets) | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
163 | Active Investigational Treatment ENT-01 | - | - | - | - | 1件: 6 6 |
164 | Active tDCS | - | - | - | - | 1件: 6 6 |
165 | Active tPCS | - | - | - | - | 1件: 6 6 |
166 | AD-810N (zonisamide) | 1件: Zonisamide Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 1件: 6 6 |
167 | Adaptor: Hakko Adaptor | - | - | - | - | 1件: 6 6 |
168 | Adjuvant without active component | - | - | - | - | 2件: 6 6, 17 |
169 | Administration of stable isotope-labelled leucine- | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 1件: 6 6 |
170 | ADS-5102 | - | - | - | - | 2件: 6 6, 13 |
171 | ADS-5102 (extended release amantadine HCl) | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
172 | ADX48621 | - | - | - | - | 1件: 6 6 |
173 | AFFITOPE® PD01A | - | - | - | - | 1件: 6 6 |
174 | AFFITOPE® PD01A + Adjuvant | - | - | - | - | 2件: 6 6, 17 |
175 | AFQ056 | - | - | - | - | 3件: 6 6, 8, 206 |
176 | AFQ056 with L-dopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
177 | AFQ065 | - | - | - | - | 1件: 6 6 |
178 | Agomelatine | 1件: Agomelatine Agomelatine | 1件: D02578
D02578
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
179 | Agomelatine or PIacebo | 1件: Agomelatine Agomelatine | 1件: D02578
D02578
| 3件: HTR2C HTR2C, MTNR1A, MTNR1B 💬 | 6件: Calcium signaling pathway Calcium signaling pathway, Circadian entrainment, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
180 | AHA | - | - | - | - | 1件: 6 6 |
181 | AHA Exergame System | - | - | - | - | 1件: 6 6 |
182 | AKST4290 | - | - | - | - | 2件: 6 6, 162 |
183 | Alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 5件: 6 6, 13, 251, 298, 299 |
184 | Allogeneic bone marrow-derived MSCs (1 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
185 | Allogeneic bone marrow-derived MSCs (10 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
186 | Allogeneic bone marrow-derived MSCs (3 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
187 | Allogeneic bone marrow-derived MSCs (6 x 10 6 MSC/kg) | - | - | - | - | 1件: 6 6 |
188 | Allopurinol | 1件: Allopurinol Allopurinol | 1件: D00224
D00224
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 6件: 6 6, 46, 57, 66, 96, 97 |
189 | AlloRx | - | - | - | - | 8件: 2 2, 6, 13, 46, 51, 85, 90, 226 |
190 | Alternating, 10 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
191 | Alternating, 10 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
192 | Alternating, 50 sec High-Frequency, 10 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
193 | Alternating, 50 sec High-Frequency, 50 sec Low-Frequency Stimulation | - | - | - | - | 1件: 6 6 |
194 | Altropane | 1件: Altropane Altropane | - | - | - | 1件: 6 6 |
195 | ALTROPANE® | 1件: Altropane Altropane | - | - | - | 1件: 6 6 |
196 | Amantadin-ratiopharm 100mg | - | - | - | - | 1件: 6 6 |
197 | AMANTADINE | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 4件: 6 6, 8, 13, 127 |
198 | Amantadine 300 mg | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
199 | Amantadine HCl ER | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
200 | Amantadine HCl Extended Release | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
201 | Amantadine HCl Extended Release Capsule | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
202 | AMANTADINE HYDROCHLORIDE | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
203 | Amantadine hydrochloride (HCl) | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
204 | Amantadine sulfate | 2件: Amantadine Amantadine, Sulfate ion | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
205 | AMBROSAN 60mg Tablets | - | - | - | - | 1件: 6 6 |
206 | Ambroxol | 1件: Ambroxol Ambroxol | 1件: D07442
D07442
| - | - | 2件: 6 6, 19 |
207 | Ambroxol Hydrochloride | 1件: Ambroxol Ambroxol | 1件: D07442
D07442
| - | - | 1件: 6 6 |
208 | Amoxicillin | 1件: Amoxicillin Amoxicillin | 3件: D00229
D00229
,
D02925
,
D07452
| - | - | 7件: 6 6, 46, 63, 96, 97, 222, 299 |
209 | Ampreloxetine | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
210 | Ampreloxetine chydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
211 | Ampreloxetine hydrochloride | 1件: Ampreloxetine Ampreloxetine | 1件: D11688
D11688
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 17 |
212 | Ampyra | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 2件: 6 6, 13 |
213 | Ampyra first, | 1件: Dalfampridine Dalfampridine | 1件: D04127
D04127
| 4件: KCNA4 KCNA4, KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 | 1件: 6 6 |
214 | ANAVEX2-73 | - | - | - | - | 2件: 6 6, 156 |
215 | ANHYDROUS CARBIDOPA | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
216 | Anle138b | 1件: anle138b anle138b | - | - | - | 1件: 6 6 |
217 | Anti-Parkinson medication | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
218 | Anti-Parkinsonian Drugs | - | - | - | - | 1件: 6 6 |
219 | Antiparkinsonian Agent(s) | - | - | - | - | 1件: 6 6 |
220 | AP | - | - | - | - | 4件: 2 2, 6, 13, 299 |
221 | AP-CD/LD | - | - | - | - | 1件: 6 6 |
222 | AP09004 | - | - | - | - | 1件: 6 6 |
223 | APL-130277 | - | - | - | - | 1件: 6 6 |
224 | Aplindore | 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 |
225 | Aplindore MR tablets | 1件: Aplindore Aplindore | - | - | - | 1件: 6 6 |
226 | APO-go | - | - | - | - | 1件: 6 6 |
227 | APO-go® | - | - | - | - | 1件: 6 6 |
228 | APOKINON | - | - | - | - | 1件: 6 6 |
229 | APOKYN | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
230 | Apomor | - | - | - | - | 1件: 6 6 |
231 | Apomorfina | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
232 | APOMORFINA CLORIDRATO | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
233 | Apomorp | - | - | - | - | 1件: 6 6 |
234 | Apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 5 5, 6, 7 |
235 | Apomorphine 0.25% (2.5mg/ml) | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
236 | Apomorphine HCl injection | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
237 | APOMORPHINE HYDROCHLORIDE | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
238 | Apomorphine hydrochloride 1.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
239 | Apomorphine hydrochloride 2.8mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
240 | Apomorphine hydrochloride 4.0 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
241 | Apomorphine hydrochloride 5.8 mg inhalation powder, pre-dispensed | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
242 | APOMORPHINE HYDROCHLORIDE HEMIHYDRATE | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
243 | Apomorphine Hydrocloride | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
244 | Apomorphine Hydrocloride Hemihydrate | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
245 | Apomorphine infusion | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
246 | Apomorphine Injectable Solution | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
247 | Apomorphine Nasal Powder | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
248 | APORON | - | - | - | - | 1件: 6 6 |
249 | AQW051 | - | - | - | - | 1件: 6 6 |
250 | ARICEPT | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 4件: 6 6, 13, 78, 124 |
251 | Aricept 5 mg-Filmtabletten | - | - | - | - | 1件: 6 6 |
252 | Aricept 5mg-Filmtabletten | - | - | - | - | 1件: 6 6 |
253 | Aripiprazole | 1件: Aripiprazole Aripiprazole | 1件: D01164
D01164
| 4件: DRD2 DRD2, DRD3, HTR1A, HTR2A 💬 | 12件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 206 |
254 | Armodafinil | 1件: Armodafinil Armodafinil | 1件: D03215
D03215
| 1件: SLC6A3 SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 84 |
255 | Artane | - | - | - | - | 1件: 6 6 |
256 | AS2 | - | - | - | - | 1件: 6 6 |
257 | ASyn Mab | - | - | - | - | 1件: 6 6 |
258 | AT 10 | - | - | - | - | 2件: 6 6, 85 |
259 | ATH-1017 | - | - | - | - | 1件: 6 6 |
260 | ATM FOG in PD | - | - | - | - | 1件: 6 6 |
261 | Atomoxetine | 1件: Atomoxetine Atomoxetine | 2件: D02574
D02574
,
D07473
| 1件: SLC6A2 SLC6A2 💬 | 1件: Synaptic vesicle cycle Synaptic vesicle cycle 💬 | 4件: 6 6, 8, 13, 17 |
262 | Atypical Antipsychotics | - | - | - | - | 1件: 6 6 |
263 | Autologous mesenchymal stem cells | - | - | - | - | 5件: 2 2, 6, 13, 17, 46 |
264 | AV-101 | 1件: AV-101 AV-101 | - | - | - | 2件: 6 6, 86 |
265 | AVALOX - 400 | - | - | - | - | 1件: 6 6 |
266 | AVE8112 | - | - | - | - | 1件: 6 6 |
267 | AVP-923 | - | - | - | - | 3件: 2 2, 6, 13 |
268 | AVP-923-45 | - | - | - | - | 1件: 6 6 |
269 | Azathioprine | 1件: Azathioprine Azathioprine | 2件: D00238
D00238
,
D03033
| - | - | 21件: 6 6, 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 93, 94, 95, 96, 97, 162 |
270 | AZD0328 | - | - | - | - | 1件: 6 6 |
271 | AZD3241 | - | - | - | - | 2件: 6 6, 17 |
272 | AZD3241 300 mg BID | - | - | - | - | 1件: 6 6 |
273 | AZD3241 600 mg BID | - | - | - | - | 1件: 6 6 |
274 | AZD3241 Alternative titration scheme with formulation 1 or 2 | - | - | - | - | 1件: 6 6 |
275 | AZD3241 ER formulation 1 | - | - | - | - | 1件: 6 6 |
276 | AZD3241 Extended release tablets 100 mg | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
277 | AZD3241 Extended release tablets 25 mg | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
278 | Azilect | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
279 | AZILECT 1 mg comprimidos | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
280 | Azilect 1mg | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
281 | AZILECT® | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
282 | B-CIT and SPECT imaging | - | - | - | - | 1件: 6 6 |
283 | B-STN DBS | - | - | - | - | 1件: 6 6 |
284 | B6, B12, L-methylfolate | 1件: Levomefolic acid Levomefolic acid | 1件: D09353
D09353
| - | - | 1件: 6 6 |
285 | Balance | 1件: Isoxaflutole Isoxaflutole | - | - | - | 8件: 6 6, 11, 13, 81, 113, 122, 149, 299 |
286 | Balance Training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
287 | Balance Training with Nintendo Wii Fit | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
288 | Band | - | - | - | - | 2件: 6 6, 97 |
289 | Bavisant | 1件: Bavisant Bavisant | 1件: D09870
D09870
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
290 | Bavisant dihydrochloride monohydrate | 1件: Bavisant Bavisant | 1件: D09870
D09870
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
291 | BAVISANT HYDROCHLORIDE MONOHYDRATE | 1件: Bavisant Bavisant | 1件: D09870
D09870
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
292 | Beam | 1件: Tricyclazole Tricyclazole | - | - | - | 2件: 6 6, 51 |
293 | Bee venom | - | - | - | - | 1件: 6 6 |
294 | BEFIRADOL | - | - | - | - | 1件: 6 6 |
295 | Behavioral: Assessment of cognition | - | - | - | - | 1件: 6 6 |
296 | Behavioral: Assessment of depression | - | - | - | - | 1件: 6 6 |
297 | Behavioral: Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors | - | - | - | - | 1件: 6 6 |
298 | Behavioral: Assessment of quality of life | - | - | - | - | 1件: 6 6 |
299 | Behavioral: Assessment of severity of ICD (impulse control disorders) | - | - | - | - | 1件: 6 6 |
300 | Behavioral: Assessment of severity of Parkinson Disease | - | - | - | - | 1件: 6 6 |
301 | Behavioral: Attention Control | - | - | - | - | 1件: 6 6 |
302 | Behavioral: Augmented Reality Multi-Modal Training | - | - | - | - | 1件: 6 6 |
303 | Behavioral: Balance & Strengthening Exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
304 | Behavioral: Balance Training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 2件: 6 6, 13 |
305 | Behavioral: BCI-FIT active querying | - | - | - | - | 3件: 2 2, 6, 17 |
306 | Behavioral: BCI-FIT adaptive signal modeling | - | - | - | - | 3件: 2 2, 6, 17 |
307 | Behavioral: BCI-FIT language modeling | - | - | - | - | 3件: 2 2, 6, 17 |
308 | Behavioral: BCI-FIT multi-modal access | - | - | - | - | 3件: 2 2, 6, 17 |
309 | Behavioral: Brisk walking and balance training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
310 | Behavioral: Building Better Caregivers Workshop | - | - | - | - | 1件: 6 6 |
311 | Behavioral: CBT and sleep hygiene | - | - | - | - | 1件: 6 6 |
312 | Behavioral: CO-OP treatment protocol | - | - | - | - | 1件: 6 6 |
313 | Behavioral: Cognitive and Behavioral experimental tasks | - | - | - | - | 2件: 6 6, 127 |
314 | Behavioral: Combined balance and brisk walking training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
315 | Behavioral: Conservative Measures for Orthostatic Hypotension | - | - | - | - | 2件: 6 6, 17 |
316 | Behavioral: Dexterity | - | - | - | - | 1件: 6 6 |
317 | Behavioral: Dual Task | - | - | - | - | 1件: 6 6 |
318 | Behavioral: ECOCAPTURE | - | - | - | - | 2件: 6 6, 127 |
319 | Behavioral: Emotion Assessment | - | - | - | - | 1件: 6 6 |
320 | Behavioral: Exercise | - | - | - | - | 3件: 6 6, 265, 299 |
321 | Behavioral: Exercise only | - | - | - | - | 1件: 6 6 |
322 | Behavioral: exercise+multi-modal sensory feedback (MMSF) | - | - | - | - | 1件: 6 6 |
323 | Behavioral: Flexibility and strengthening exercise | - | - | - | - | 1件: 6 6 |
324 | Behavioral: Gait and balance | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
325 | Behavioral: gait and balance training program | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
326 | Behavioral: Healthy age-matched controls | - | - | - | - | 1件: 6 6 |
327 | Behavioral: ICM_APATHY_TASKS | - | - | - | - | 2件: 6 6, 127 |
328 | Behavioral: Levodopa or acupuncture | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
329 | Behavioral: Low-Impact Exercise Control | - | - | - | - | 1件: 6 6 |
330 | Behavioral: Memory | - | - | - | - | 1件: 6 6 |
331 | Behavioral: OM Meditation | - | - | - | - | 1件: 6 6 |
332 | Behavioral: Participant open-response writing | - | - | - | - | 1件: 6 6 |
333 | Behavioral: Participant self-assessment surveys | - | - | - | - | 1件: 6 6 |
334 | Behavioral: PAT sessions | - | - | - | - | 1件: 6 6 |
335 | Behavioral: Pelvic floor muscle exercise-based behavioral therapy | - | - | - | - | 1件: 6 6 |
336 | Behavioral: Phonation | - | - | - | - | 1件: 6 6 |
337 | Behavioral: physical exam and UPDRS part III assessment | - | - | - | - | 1件: 6 6 |
338 | Behavioral: Physical Therapy | - | - | - | - | 1件: 6 6 |
339 | Behavioral: pre DBS patients responding to the DBS-PS scale | - | - | - | - | 1件: 6 6 |
340 | Behavioral: Resistance Training | - | - | - | - | 1件: 6 6 |
341 | Behavioral: Rest | - | - | - | - | 1件: 6 6 |
342 | Behavioral: Role of dopamine | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
343 | Behavioral: Single Task | - | - | - | - | 1件: 6 6 |
344 | Behavioral: steps per day | - | - | - | - | 1件: 6 6 |
345 | Behavioral: Strength training | - | - | - | - | 1件: 6 6 |
346 | Behavioral: stretching | - | - | - | - | 1件: 6 6 |
347 | Behavioral: Tai Chi | - | - | - | - | 1件: 6 6 |
348 | Behavioral: Traditional Multi-Modal Training | - | - | - | - | 1件: 6 6 |
349 | Behavioral: Upper limb exercise | - | - | - | - | 1件: 6 6 |
350 | BEN-2001 | - | - | - | - | 1件: 6 6 |
351 | BENSERAZIDE | 1件: Benserazide Benserazide | 1件: D03082
D03082
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
352 | BENSERAZIDE HYDROCHLORIDE | 1件: Benserazide Benserazide | 1件: D03082
D03082
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
353 | Benzofuran | 1件: Benzofuran Benzofuran | - | - | - | 1件: 6 6 |
354 | Berachin | - | - | - | - | 1件: 6 6 |
355 | Best Medical Treatment | - | - | - | - | 1件: 6 6 |
356 | Best médical treatment | - | - | - | - | 1件: 6 6 |
357 | Betaquik MCT supplement | - | - | - | - | 1件: 6 6 |
358 | Better | - | - | - | - | 2件: 6 6, 13 |
359 | BF 2.649 | - | - | - | - | 1件: 6 6 |
360 | BF 2.649 10 mg | - | - | - | - | 1件: 6 6 |
361 | BF 2.649 20 mg | - | - | - | - | 1件: 6 6 |
362 | BF 2.649 40 mg | - | - | - | - | 1件: 6 6 |
363 | BF 2.649 5 mg | - | - | - | - | 1件: 6 6 |
364 | BF2.649 | - | - | - | - | 1件: 6 6 |
365 | BF2.649 (Pitolisant) | 1件: Pitolisant Pitolisant | 1件: D10749
D10749
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
366 | BI-Sifrol® | - | - | - | - | 1件: 6 6 |
367 | BIA | 1件: BIA BIA | - | - | - | 2件: 6 6, 86 |
368 | BIA 3-202 | 1件: BIA BIA | - | - | - | 1件: 6 6 |
369 | BIA 3-202 (200 mg) | 1件: BIA BIA | - | - | - | 1件: 6 6 |
370 | BIA 6-512 | 1件: BIA BIA | - | - | - | 1件: 6 6 |
371 | BIA 6-512 100 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
372 | BIA 6-512 100 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 |
373 | BIA 6-512 200 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 |
374 | BIA 6-512 25 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
375 | BIA 6-512 25 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 |
376 | BIA 6-512 400 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
377 | BIA 6-512 50 mg dose | 1件: BIA BIA | - | - | - | 1件: 6 6 |
378 | BIA 9-1067 | 1件: BIA BIA | - | - | - | 1件: 6 6 |
379 | BIA 9-1067 (test) | 1件: BIA BIA | - | - | - | 1件: 6 6 |
380 | BIA 9-1067 15 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
381 | BIA 9-1067 25 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
382 | BIA 9-1067 30 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
383 | BIA 9-1067 5 mg | 1件: BIA BIA | - | - | - | 1件: 6 6 |
384 | BIA 9-1067 micronized | 1件: BIA BIA | - | - | - | 1件: 6 6 |
385 | BIA 9-1067 non-micronized | 1件: BIA BIA | - | - | - | 1件: 6 6 |
386 | BIIB014 | - | - | - | - | 1件: 6 6 |
387 | BIIB054 | - | - | - | - | 1件: 6 6 |
388 | BIIB094 | - | - | - | - | 1件: 6 6 |
389 | Biofluid samplings | - | - | - | - | 1件: 6 6 |
390 | Biological/Vaccine: Allogeneic HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 1件: 6 6 |
391 | Bisphosphonates | - | - | - | - | 2件: 6 6, 274 |
392 | Blood analysis | - | - | - | - | 1件: 6 6 |
393 | Blood draw | - | - | - | - | 5件: 6 6, 19, 65, 231, 299 |
394 | Bone marrow derived mesenchymal stem cells | - | - | - | - | 2件: 6 6, 60 |
395 | BoNT-A | - | - | - | - | 1件: 6 6 |
396 | Botox | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 6件: 2 2, 6, 13, 51, 149, 226 |
397 | Botulinum Toxin | - | - | - | - | 3件: 6 6, 13, 149 |
398 | BOTULINUM TOXIN TYPE A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 10件: 2 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 |
399 | Botulinum toxin type B | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 51 |
400 | Botulinum toxin type B (Myobloc) | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 2件: 2 2, 6 |
401 | Botulinum Toxin: Xeomin | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
402 | BROMOCRIPTINE | 1件: Bromocriptine Bromocriptine | 2件: D00780
D00780
,
D03165
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 74 |
403 | Bromocriptine and other dopamine agonists | 2件: Bromocriptine Bromocriptine, Dopamine | 4件: D00633
D00633
,
D00780
,
D03165
,
D07870
| 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, PRL 💬 | 15件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
404 | BT | - | - | - | - | 4件: 6 6, 96, 97, 98 |
405 | BTRX-246040 | 1件: BTRX-246040 BTRX-246040 | - | - | - | 1件: 6 6 |
406 | BTX-A | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
407 | Bumetanide | 1件: Bumetanide Bumetanide | 1件: D00247
D00247
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 2件: 6 6, 158 |
408 | Bumetanide white, oblong, scored tablet | 1件: Bumetanide Bumetanide | 1件: D00247
D00247
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
409 | Bupleurum+Ginkgo | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 1件: 6 6 |
410 | Buspirone | 1件: Buspirone Buspirone | 2件: D00702
D00702
,
D07593
| 2件: DRD2 DRD2, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 51, 179 |
411 | Buspirone Hydrochloride | 1件: Buspirone Buspirone | 2件: D00702
D00702
,
D07593
| 2件: DRD2 DRD2, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
412 | Butylphthalide | 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 18, 22 |
413 | BYDUREON | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 2件: 6 6, 17 |
414 | Bydureon 2 mg powder and solvent for prolonged-release suspension | 2件: Exenatide Exenatide, Manganese citrate | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
415 | Byetta | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 78, 193 |
416 | Byetta 5 micrograms | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
417 | Cabaser | - | - | - | - | 1件: 6 6 |
418 | Cabaseril | - | - | - | - | 1件: 6 6 |
419 | Cabaseril, 1,0 mg Tablette | - | - | - | - | 1件: 6 6 |
420 | Cabaseril, 2,0 mg Tablette | - | - | - | - | 1件: 6 6 |
421 | CABERGOLINA | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 75 |
422 | Cabergoline | 1件: Cabergoline Cabergoline | 1件: D00987
D00987
| 2件: DRD2 DRD2, PRL 💬 | 12件: Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 74, 75 |
423 | CADD-Legacy ambulatory infusion pump | - | - | - | - | 1件: 6 6 |
424 | CADD-Legacy® 1400 ambulatory infusion pump | - | - | - | - | 1件: 6 6 |
425 | Caffeine | 1件: Caffeine Caffeine | 2件: D00528
D00528
,
D01453
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 9件: 2 2, 6, 13, 21, 46, 78, 96, 97, 265 |
426 | Caffeine 100-200 mg BID | 1件: Caffeine Caffeine | 2件: D00528
D00528
,
D01453
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
427 | Caffeine alkaloid | 1件: Caffeine Caffeine | 2件: D00528
D00528
,
D01453
| 11件: ADORA1 ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 | 22件: Alcoholism Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
428 | Calcium | 1件: Calcium Calcium | - | - | - | 30件: 3 3, 6, 13, 15, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 256, 265, 274, 298, 299 |
429 | Cannabidiol | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 18件: 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
430 | Cannabidiol (CBD) | 1件: Cannabidiol Cannabidiol | 1件: D10915
D10915
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 7件: 6 6, 13, 140, 144, 145, 156, 158 |
431 | Cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 9件: 2 2, 6, 13, 19, 46, 90, 96, 97, 271 |
432 | Cannabis Oil | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 6 6 |
433 | Cannabis, Medical | 1件: Medical Cannabis Medical Cannabis | - | - | - | 5件: 2 2, 6, 13, 96, 97 |
434 | Capsaicin | 1件: Capsaicin Capsaicin | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 5件: 2 2, 6, 19, 86, 226 |
435 | Capsaicin vapor | 1件: Capsaicin Capsaicin | 1件: D00250
D00250
| 1件: TRPV1 TRPV1 💬 | 2件: Inflammatory mediator regulation of TRP channels Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
436 | Capsules containing: carbidopa (25 mg), levodopa (100 mg), entacapone (200 mg) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
437 | CAPTURE | 1件: Bifenthrin Bifenthrin | - | - | - | 2件: 6 6, 46 |
438 | Carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 9件: 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
439 | CARBIDOPA (CD) | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
440 | CARBIDOPA (FU) | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
441 | Carbidopa 20 mg | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
442 | Carbidopa 200mg oral dose | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
443 | Carbidopa 27.5 mg | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
444 | Carbidopa 65 mg capsule | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
445 | Carbidopa and Levodopa 25mg/100mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
446 | Carbidopa and Levodopa Controlled Release Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
447 | Carbidopa and Levodopa Tablets, USP | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
448 | CARBIDOPA ANIDRA | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
449 | CARBIDOPA FU | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
450 | CARBIDOPA INN | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
451 | CARBIDOPA LEVODOPA | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
452 | CARBIDOPA MONOHYDRATE | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
453 | Carbidopa Pill | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
454 | Carbidopa, levodopa, entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
455 | Carbidopa- Levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
456 | Carbidopa-4'-Monophosphate | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
457 | Carbidopa-levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 3件: 2 2, 4, 6 |
458 | Carbidopa-Levodopa 25 Mg-100 Mg Oral Tablet | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
459 | Carbidopa/l-dopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
460 | Carbidopa/l-dopa/entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
461 | Carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
462 | Carbidopa/levodopa, as prescribed by treating physician | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
463 | Carbidopa/Levodopa, immediate release | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
464 | Carbidopa/Levodopa/Entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
465 | Carbidopamonohydraat | - | - | - | - | 1件: 6 6 |
466 | CARBODOPA LEVADOPA | - | - | - | - | 1件: 6 6 |
467 | Carbodopa/levadopa | - | - | - | - | 1件: 6 6 |
468 | Carbon | 1件: Activated charcoal Activated charcoal | - | - | - | 9件: 6 6, 46, 50, 51, 85, 86, 96, 97, 298 |
469 | Carbon Fiber Ankle Foot Orthosis (AFO) | 1件: Activated charcoal Activated charcoal | - | - | - | 1件: 6 6 |
470 | Carbon-14 BIA 28-6156 | 2件: Activated charcoal Activated charcoal, BIA | - | - | - | 1件: 6 6 |
471 | Cardiac monitoring | - | - | - | - | 1件: 6 6 |
472 | Carnosine | 1件: Carnosine Carnosine | - | - | - | 2件: 6 6, 13 |
473 | Carnosine supplementation | 1件: Carnosine Carnosine | - | - | - | 1件: 6 6 |
474 | Carvedilol | 1件: Carvedilol Carvedilol | 2件: D00255
D00255
,
D03415
| 5件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRB1, ADRB2 💬 | 13件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 6 6, 57, 86, 113, 210 |
475 | Catapres ampoules | 1件: Clonidine Clonidine | 2件: D00281
D00281
,
D00604
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
476 | Catapressan | - | - | - | - | 1件: 6 6 |
477 | CBD | - | - | - | - | 12件: 2 2, 6, 8, 13, 36, 46, 140, 144, 145, 156, 158, 206 |
478 | CD | - | - | - | - | 7件: 6 6, 13, 46, 51, 96, 97, 265 |
479 | CD-LD CR | - | - | - | - | 1件: 6 6 |
480 | CD-LD IR | - | - | - | - | 1件: 6 6 |
481 | CDNF | - | - | - | - | 1件: 6 6 |
482 | Ceftriaxone | 1件: Ceftriaxone Ceftriaxone | 2件: D00924
D00924
,
D07659
| - | - | 3件: 2 2, 6, 97 |
483 | CEP-1347 | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 |
484 | CEP-1347 10mg | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 |
485 | CEP-1347 50mg | 1件: CEP-1347 CEP-1347 | - | - | - | 1件: 6 6 |
486 | CEP1347 | - | - | - | - | 1件: 6 6 |
487 | CEP1347 25mg | - | - | - | - | 1件: 6 6 |
488 | CERE-120 | - | - | - | - | 1件: 6 6 |
489 | CERE-120 (Adeno-Associated Virus Serotype 2 [AAV2]-Neurturin [NTN]) | - | - | - | - | 1件: 6 6 |
490 | CERE-120: Adeno-Associated Virus Delivery of Neurturin | - | - | - | - | 1件: 6 6 |
491 | Cerebral Dopamine Neurotrophic Factor | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
492 | Ceretec | 1件: Technetium Tc-99m exametazime Technetium Tc-99m exametazime | - | - | - | 1件: 6 6 |
493 | CERETEC (TM) Estabilizado | 1件: Technetium Tc-99m exametazime Technetium Tc-99m exametazime | - | - | - | 1件: 6 6 |
494 | Champix | 1件: Varenicline Varenicline | 1件: D08669
D08669
| 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 1件: 6 6 |
495 | Chinese herbal medicine treatment | - | - | - | - | 1件: 6 6 |
496 | Chloride | 1件: Chloride ion Chloride ion | - | - | - | 29件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 97, 107, 127, 168, 171, 193, 227, 228, 251, 271, 288, 296, 297, 299, 338 |
497 | Chocolate | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
498 | CIPRALEX | - | - | - | - | 1件: 6 6 |
499 | Circadin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 13, 90 |
500 | Circadin® | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
501 | Citalopram | 1件: Citalopram Citalopram | 2件: D00822
D00822
,
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 |
502 | Citalopram 20mg | 1件: Citalopram Citalopram | 2件: D00822
D00822
,
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
503 | Citicolin | - | - | - | - | 1件: 6 6 |
504 | CITICOLIN*1G/4ML IM IV 5 F | - | - | - | - | 1件: 6 6 |
505 | Citicolina | 1件: Citicoline Citicoline | 1件: D00057
D00057
| - | - | 1件: 6 6 |
506 | Citicolina 1000 mg/die | 1件: Citicoline Citicoline | 1件: D00057
D00057
| - | - | 1件: 6 6 |
507 | CITICOLINA SODICA | 1件: Citicoline Citicoline | 1件: D00057
D00057
| - | - | 1件: 6 6 |
508 | CJH1 (CLR4001) | - | - | - | - | 1件: 6 6 |
509 | Clarithromycin | 1件: Clarithromycin Clarithromycin | 1件: D00276
D00276
| - | - | 8件: 6 6, 63, 84, 96, 97, 222, 228, 299 |
510 | Clarithromycin (Not used as of 4/2020) | 1件: Clarithromycin Clarithromycin | 1件: D00276
D00276
| - | - | 1件: 6 6 |
511 | Clarium 50 mg Retardtabletten | - | - | - | - | 1件: 6 6 |
512 | Clartihromycin, amoxicillin, and omeprazole | 2件: Amoxicillin Amoxicillin, Omeprazole | 7件: D00229
D00229
,
D00455
,
D01207
,
D02925
,
D05259
,
D05261
,
D07452
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 1件: 6 6 |
513 | CLE | - | - | - | - | 1件: 6 6 |
514 | Clenbuterol | 1件: Clenbuterol Clenbuterol | 1件: D07713
D07713
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 1 1, 2, 6, 256 |
515 | Clenbuterol HCl | 1件: Clenbuterol Clenbuterol | 1件: D07713
D07713
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
516 | CLENBUTEROL HYDROCHLORIDE | 1件: Clenbuterol Clenbuterol | 1件: D07713
D07713
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
517 | Clonazepam | 1件: Clonazepam Clonazepam | 1件: D00280
D00280
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
518 | Clonidine | 1件: Clonidine Clonidine | 2件: D00281
D00281
,
D00604
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 65, 70, 78 |
519 | Clonidine (Catapressan) | 1件: Clonidine Clonidine | 2件: D00281
D00281
,
D00604
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
520 | Clonidine hydrochloride | 1件: Clonidine Clonidine | 2件: D00281
D00281
,
D00604
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 78 |
521 | CLOZAPINE | 1件: Clozapine Clozapine | 1件: D00283
D00283
| 11件: ADRA2A ADRA2A, ADRA2B, ADRA2C, DRD4, HTR2A, HTR2C, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 8件: Calcium signaling pathway Calcium signaling pathway, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
522 | CO | - | - | - | - | 6件: 6 6, 13, 53, 70, 85, 149 |
523 | Coarse wheat bran | 2件: Wheat Wheat, Wheat bran | 1件: D06902
D06902
| - | - | 1件: 6 6 |
524 | Cocoa | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
525 | Coenzyme Q10 | 1件: Ubidecarenone Ubidecarenone | 1件: D01065
D01065
| - | - | 12件: 2 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215 |
526 | Coenzyme Q10 Nanodispersion (Nanoquinone) | 1件: Ubidecarenone Ubidecarenone | 1件: D01065
D01065
| - | - | 1件: 6 6 |
527 | Coenzyme Q10 with vitamin E | 2件: Ubidecarenone Ubidecarenone, Vitamin E | 2件: D01065
D01065
,
D02331
| - | - | 1件: 6 6 |
528 | CoFactor | - | - | - | - | 3件: 6 6, 265, 288 |
529 | Cogane | - | - | - | - | 1件: 6 6 |
530 | Cogane™ (PYM50028) | - | - | - | - | 1件: 6 6 |
531 | Cohort 1:Nilotinib Oral Capsules (150mg or 300mg) | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
532 | Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1) | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
533 | Combination injection of EPO and G-CSF | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 6 6 |
534 | Combination Product: continuous oral delivery of levodopa/carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
535 | Combination Product: L-dopa 140 mg | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
536 | Combination Product: L-dopa 35 mg | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
537 | Combination Product: L-dopa 70mg | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
538 | Combination Product: L-dopa 70mg/carbidopa 7mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
539 | Combination Product: ND0612 Solution for SC infusion | - | - | - | - | 1件: 6 6 |
540 | Combination Product: Sanacoach Parkinson (SCP) | - | - | - | - | 1件: 6 6 |
541 | Comparator: carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
542 | Comparator: levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
543 | COMTAN | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
544 | COMTAN 200* 60 CPR 200 MG | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
545 | COMTAN® | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
546 | Comtan® | - | - | - | - | 1件: 6 6 |
547 | Comtess | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
548 | Comtess® | - | - | - | - | 1件: 6 6 |
549 | Continuous Apomorphine infusion | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
550 | Continuous intrajejunal infusion of levodopa-carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
551 | Continuous Release Dopamine Agonists | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
552 | Continuous Subcutaneous Lisuride Infusion | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
553 | Control | - | - | - | - | 4件: 6 6, 46, 168, 299 |
554 | Controlled-release levodopa / carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
555 | Conventional medication | - | - | - | - | 1件: 6 6 |
556 | CoQ10 | - | - | - | - | 3件: 5 5, 6, 8 |
557 | Cord blood therapy | 1件: Umbilical Cord Blood Hematopoietic Stem Cells Umbilical Cord Blood Hematopoietic Stem Cells | - | - | - | 2件: 2 2, 6 |
558 | Cortef | 1件: Hydrocortisone cypionate Hydrocortisone cypionate | 1件: D00976
D00976
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 |
559 | CP | - | - | - | - | 6件: 6 6, 46, 96, 97, 107, 271 |
560 | CPL500036 | - | - | - | - | 1件: 6 6 |
561 | Creatine | 1件: Creatine Creatine | - | - | - | 16件: 1 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 113, 156, 201, 256 |
562 | CST-103 | - | - | - | - | 1件: 6 6 |
563 | CST-107 | - | - | - | - | 1件: 6 6 |
564 | CST-139 | - | - | - | - | 1件: 6 6 |
565 | Cu(II)ATSM | - | - | - | - | 2件: 2 2, 6 |
566 | CVD00118-E | - | - | - | - | 1件: 6 6 |
567 | CVL-751 | - | - | - | - | 1件: 6 6 |
568 | CVN424 High Dose | - | - | - | - | 1件: 6 6 |
569 | CVN424 Low Dose | - | - | - | - | 1件: 6 6 |
570 | CVT-301 | - | - | - | - | 1件: 6 6 |
571 | CVT-301 (Dose Level 1) | - | - | - | - | 1件: 6 6 |
572 | CVT-301 (Dose Level 2) | - | - | - | - | 1件: 6 6 |
573 | CVT-301 35mg | - | - | - | - | 1件: 6 6 |
574 | CVT-301 50mg | - | - | - | - | 1件: 6 6 |
575 | CVT-301 High Dose | - | - | - | - | 1件: 6 6 |
576 | CVT-301 Low Dose | - | - | - | - | 1件: 6 6 |
577 | CVT-301, LIP | - | - | - | - | 1件: 6 6 |
578 | CVXL-0107 | - | - | - | - | 1件: 6 6 |
579 | CX-8998 | - | - | - | - | 1件: 6 6 |
580 | CyberKnife | - | - | - | - | 1件: 6 6 |
581 | CYMBALTA | - | - | - | - | 3件: 6 6, 13, 49 |
582 | Cysteine | 1件: Cysteine Cysteine | 2件: D00026
D00026
,
D02326
| - | - | 11件: 6 6, 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 |
583 | Cystoscopic injection of Botox into the urinary bladder | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
584 | D-Serine | 2件: D-Serine D-Serine, Serine | 1件: D00016
D00016
| - | - | 1件: 6 6 |
585 | D-serine (~2g/day) | 2件: D-Serine D-Serine, Serine | 1件: D00016
D00016
| - | - | 1件: 6 6 |
586 | DA-9701 | - | - | - | - | 1件: 6 6 |
587 | DA-9805 45mg | - | - | - | - | 1件: 6 6 |
588 | DA-9805 90mg | - | - | - | - | 1件: 6 6 |
589 | DAAOI-P | - | - | - | - | 1件: 6 6 |
590 | Dacepton 5 mg/ml | - | - | - | - | 1件: 6 6 |
591 | Dacepton 5 mg/ml infuusioneste, liuos | - | - | - | - | 1件: 6 6 |
592 | Daily ingestion of Lactobacillus plantarum PS128 | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 1件: 6 6 |
593 | Darifenacin | 1件: Darifenacin Darifenacin | 2件: D01699
D01699
,
D03654
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 2件: 6 6, 13 |
594 | Dark chocolate (85% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
595 | DaTSCAN | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 4件: 2 2, 5, 6, 17 |
596 | DaTSCAN 74 MBq/ml solution for injection | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
597 | DATscan and SPECT imaging | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
598 | DaTSCAN™ | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
599 | DaTSCAN™ Ioflupane (123I) Injection | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 3件: 5 5, 6, 17 |
600 | DC158AM | - | - | - | - | 1件: 6 6 |
601 | DCI | - | - | - | - | 2件: 6 6, 299 |
602 | DCS | - | - | - | - | 1件: 6 6 |
603 | Deanol | 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
604 | Deanol pyroglutamate | 1件: Deanol Deanol | 1件: D07777
D07777
| - | - | 1件: 6 6 |
605 | DEBRUMYL | - | - | - | - | 1件: 6 6 |
606 | Deep Brain Stimulation | - | - | - | - | 5件: 5 5, 6, 7, 8, 17 |
607 | DEFERIPRONE | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
608 | Deferiprone (Ferriprox) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
609 | Deferiprone 20mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
610 | Deferiprone 30mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
611 | Deferiprone 600 mg delayed release tablet | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
612 | Deferiprone DR | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 2件: 2 2, 6 |
613 | Desmopressin | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 5件: 6 6, 64, 72, 225, 288 |
614 | Desmopressin Acetat | 1件: Desmopressin Desmopressin | 2件: D00291
D00291
,
D02235
| 2件: AVPR2 AVPR2, F8 💬 | 4件: Complement and coagulation cascades Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬 | 1件: 6 6 |
615 | Desmotabs | - | - | - | - | 1件: 6 6 |
616 | Desmotabs® 0,2 mg Tabletten | - | - | - | - | 1件: 6 6 |
617 | Desmotabs® 0,2mg Tabletten | - | - | - | - | 1件: 6 6 |
618 | Determination of drug effects through amantadine cessation | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
619 | Dexdor | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 4件: 2 2, 4, 6, 70 |
620 | DEXMEDETOMIDINA | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
621 | DEXMEDETOMIDINE | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 13件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 212, 215, 226, 280 |
622 | Dexmedetomidine Hydrochloride Infusion | 1件: Dexmedetomidine Dexmedetomidine | 2件: D00514
D00514
,
D01205
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
623 | Dextromethorphan | 1件: Dextromethorphan Dextromethorphan | 3件: D00848
D00848
,
D03742
,
D03744
| 6件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 11件: 2 2, 6, 8, 13, 21, 46, 78, 85, 96, 97, 156 |
624 | DHA | - | - | - | - | 8件: 6 6, 46, 48, 49, 94, 113, 299, 301 |
625 | Diagnostic Test: [18F]-RO6958948 | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
626 | Diagnostic Test: Auto-Assessment Manikins (SAM) | - | - | - | - | 1件: 6 6 |
627 | Diagnostic Test: Barcelona test (BT) | - | - | - | - | 1件: 6 6 |
628 | Diagnostic Test: Beam test to predict falls | 1件: Tricyclazole Tricyclazole | - | - | - | 1件: 6 6 |
629 | Diagnostic Test: Beck Depression Inventory-II (BDI-II) | - | - | - | - | 1件: 6 6 |
630 | Diagnostic Test: Elecsys (Roche) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
631 | Diagnostic Test: Flutemetamol F18 Injection | 2件: Flutemetamol Flutemetamol, Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
632 | Diagnostic Test: Frontal assessment battery (FAB) | - | - | - | - | 1件: 6 6 |
633 | Diagnostic Test: Global Deterioration Scale (GDS) | - | - | - | - | 1件: 6 6 |
634 | Diagnostic Test: Lumipulse (Fujirebio) Abeta42, Ttau and Ptau | - | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
635 | Diagnostic Test: Measurement of serum level of anti-dementia drug | - | - | - | - | 1件: 6 6 |
636 | Diagnostic Test: Memory alteration test (M@T) | - | - | - | - | 1件: 6 6 |
637 | Diagnostic Test: Mini Cognitive Examination (MCE) | - | - | - | - | 1件: 6 6 |
638 | Diagnostic Test: Neuropsychological assessment | - | - | - | - | 2件: 6 6, 127 |
639 | Diagnostic Test: Positive and Negative Affect Scale (PANAS) | - | - | - | - | 1件: 6 6 |
640 | Diagnostic Test: Respiratory Muscle Strength | - | - | - | - | 1件: 6 6 |
641 | Diagnostic Test: Rey-Osterrieth Complex Figure Test (ROCFT) | - | - | - | - | 1件: 6 6 |
642 | Diagnostic Test: Spanish-Complutense Verbal Learning Test (TAVEC) | - | - | - | - | 1件: 6 6 |
643 | Diagnostic Test: Supplementary Neuropsychological Assessment - Parkinson's Disease | - | - | - | - | 2件: 6 6, 127 |
644 | Different diets | - | - | - | - | 1件: 6 6 |
645 | Dihydroergotoxine | 1件: Dihydroergotoxine Dihydroergotoxine | 1件: D07839
D07839
| - | - | 1件: 6 6 |
646 | Dihydroergotoxine Mesylate | 2件: Dihydroergotoxine Dihydroergotoxine, Ergoloid mesylate | 2件: D02268
D02268
,
D07839
| 6件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
647 | Dipivefrin | 1件: Dipivefrin Dipivefrin | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
648 | Dipivefrine | 1件: Dipivefrin Dipivefrin | 1件: D02349
D02349
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
649 | Dipraglurant | 1件: Dipraglurant Dipraglurant | - | - | - | 1件: 6 6 |
650 | Ditropan elixir | 1件: Oxybutynin Oxybutynin | 2件: D00465
D00465
,
D00722
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
651 | DM | - | - | - | - | 2件: 6 6, 8 |
652 | DM-1992 | - | - | - | - | 1件: 6 6 |
653 | DNL151 | - | - | - | - | 1件: 6 6 |
654 | DNL201 | - | - | - | - | 1件: 6 6 |
655 | DNS-7801 (high dose) | - | - | - | - | 1件: 6 6 |
656 | DNS-7801 (low-dose) | - | - | - | - | 1件: 6 6 |
657 | Docosahexaenoic acid | 1件: Doconexent Doconexent | - | - | - | 7件: 6 6, 49, 90, 94, 240, 299, 301 |
658 | Docosahexaenoic Acid (DHA) | 1件: Doconexent Doconexent | - | - | - | 3件: 6 6, 94, 299 |
659 | Domperidone | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 5件: 6 6, 13, 17, 51, 230 |
660 | Domperidone (drug) | 1件: Domperidone Domperidone | 2件: D01745
D01745
,
D07868
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
661 | Dompéridone | - | - | - | - | 1件: 6 6 |
662 | Donepezil | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 9件: 5 5, 6, 13, 46, 78, 124, 127, 156, 206 |
663 | Donepezil hydrochloride | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 6 6, 124, 156 |
664 | Donepezil Sandoz | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
665 | DopaFuse Delivery System | - | - | - | - | 1件: 6 6 |
666 | Dopamine | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 7, 74 |
667 | Dopamine Agent | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
668 | Dopamine Agonists (pramipexole, ropirinole) | 2件: Dopamine Dopamine, Pramipexole | 4件: D00559
D00559
,
D00633
,
D05575
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
669 | Dopaminergic Agonist + Apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
670 | Dopaminergic Agonists | - | - | - | - | 1件: 6 6 |
671 | DOPS | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 17 |
672 | Doxepin | 1件: Doxepin Doxepin | 2件: D00814
D00814
,
D07875
| 3件: HRH1 HRH1, SLC6A2, SLC6A4 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
673 | Doxepin and Zopiclone | 2件: Doxepin Doxepin, Zopiclone | 3件: D00814
D00814
,
D01372
,
D07875
| 19件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, HRH1, SLC6A2, SLC6A4 💬 | 10件: Calcium signaling pathway Calcium signaling pathway, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction 💬 | 1件: 6 6 |
674 | DPA | - | - | - | - | 5件: 2 2, 6, 13, 85, 127 |
675 | DPA-714-PET/MRI | - | - | - | - | 1件: 6 6 |
676 | Droxidopa | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 5件: 5 5, 6, 17, 169, 170 |
677 | Droxidopa 100 MG [Northera] | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
678 | Duloxetine | 1件: Duloxetine Duloxetine | 2件: D01179
D01179
,
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
679 | Duloxetine hydrochloride | 1件: Duloxetine Duloxetine | 2件: D01179
D01179
,
D07880
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
680 | DUODOPA | - | - | - | - | 1件: 6 6 |
681 | Duodopa gel intestinale | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
682 | Duodopa intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
683 | Duodopa intestinalgel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
684 | Duodopa LD/CD 20/5 mg/mL | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
685 | Duodopa, 20 mg/ml + 5 mg/ml, intestinal gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
686 | Duodopa, levodopa 20 mg/ml + carbidopa 5 mg/ml, intestinal gel | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
687 | DUODOPA®Intestinal Gel | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
688 | Dynacirc CR (Isradipine) | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
689 | E2007 | - | - | - | - | 2件: 6 6, 144 |
690 | E2027 | - | - | - | - | 1件: 6 6 |
691 | EBIXA | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 13 |
692 | EBIXA® | - | - | - | - | 1件: 6 6 |
693 | EGCG | 1件: Epigallocatechin gallate Epigallocatechin gallate | - | - | - | 9件: 6 6, 8, 13, 17, 28, 85, 113, 206, 299 |
694 | ELC200 | - | - | - | - | 1件: 6 6 |
695 | Electroacupuncture | - | - | - | - | 2件: 6 6, 70 |
696 | Eliprodil | 1件: Eliprodil Eliprodil | - | - | - | 1件: 6 6 |
697 | Elobixibat | 1件: Elobixibat Elobixibat | 1件: D10796
D10796
| 1件: SLC10A2 SLC10A2 💬 | 1件: Bile secretion Bile secretion 💬 | 1件: 6 6 |
698 | ELTOPRAZINE | 1件: Eltoprazine Eltoprazine | - | - | - | 1件: 6 6 |
699 | Eltoprazine HCl | 1件: Eltoprazine Eltoprazine | - | - | - | 1件: 6 6 |
700 | Eltoprazine Hydrochloride | 1件: Eltoprazine Eltoprazine | - | - | - | 1件: 6 6 |
701 | Embryonic dopamine cell implant surgery | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
702 | EMD 128130 | - | - | - | - | 2件: 6 6, 156 |
703 | EMD128130 | - | - | - | - | 1件: 6 6 |
704 | EN | - | - | - | - | 3件: 6 6, 46, 97 |
705 | ENA713 | - | - | - | - | 2件: 6 6, 13 |
706 | ENA713B | - | - | - | - | 1件: 6 6 |
707 | ENT-01 | - | - | - | - | 1件: 6 6 |
708 | Entacapon | - | - | - | - | 1件: 6 6 |
709 | ENTACAPONA | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
710 | ENTACAPONE | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
711 | Entacapone 400mg oral dose | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
712 | Entacapone and carbidopa | 2件: Carbidopa Carbidopa, Entacapone | 2件: D00558
D00558
,
D00781
| 2件: COMT COMT, DDC 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
713 | ENTACAPONE INN | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
714 | Entecapone | - | - | - | - | 1件: 6 6 |
715 | EPI-589 | 1件: EPI-589 EPI-589 | - | - | - | 2件: 2 2, 6 |
716 | EPI-743 200mg | - | - | - | - | 1件: 6 6 |
717 | EPI-743 400mg | - | - | - | - | 1件: 6 6 |
718 | Equal | - | - | - | - | 5件: 6 6, 13, 67, 86, 230 |
719 | Equfina | - | - | - | - | 1件: 6 6 |
720 | Equfina 50 mg | - | - | - | - | 1件: 6 6 |
721 | ER CD-LD | - | - | - | - | 1件: 6 6 |
722 | ER tablet 100 mg AZD3241 | - | - | - | - | 1件: 6 6 |
723 | ER tablet 25 mg AZD3241 | - | - | - | - | 1件: 6 6 |
724 | Eradication of Helcobacter Pylori | - | - | - | - | 1件: 6 6 |
725 | Eradication therapy for H.pylori infection | - | - | - | - | 1件: 6 6 |
726 | Eradication therapy for Helicobacter pylori | - | - | - | - | 1件: 6 6 |
727 | Erythromycin | 1件: Erythromycin Erythromycin | 9件: D00140
D00140
,
D00851
,
D01361
,
D02009
,
D02184
,
D02523
,
D02524
,
D02525
,
D04054
| - | - | 5件: 6 6, 36, 164, 228, 291 |
728 | ERYTHROPOIETIN | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 9件: 2 2, 6, 13, 18, 22, 47, 70, 95, 96 |
729 | Erythropoietin human recombinant (EPOrh) | 1件: Erythropoietin Erythropoietin | 1件: D03231
D03231
| 1件: EPOR EPOR 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 1件: 6 6 |
730 | Escitalopram | 1件: Escitalopram Escitalopram | 3件: D02567
D02567
,
D07704
,
D07913
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 2 2, 6, 13 |
731 | Escitalopram oxalate | 1件: Escitalopram Escitalopram | 3件: D02567
D02567
,
D07704
,
D07913
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
732 | Eszopiclone | 1件: Eszopiclone Eszopiclone | 1件: D02624
D02624
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 6 6, 13, 46 |
733 | ETHNODYNE VISIO | - | - | - | - | 1件: 6 6 |
734 | Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester (**See other 2 names below) | - | - | - | - | 1件: 6 6 |
735 | Etomidate | 1件: Etomidate Etomidate | 1件: D00548
D00548
| 1件: GABRA1 GABRA1 💬 | 6件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Taste transduction 💬 | 1件: 6 6 |
736 | Exametazime | 1件: Exametazime Exametazime | 1件: D01109
D01109
| - | - | 1件: 6 6 |
737 | EXELON | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 13 |
738 | Exelon 4.6 mg/24 h transdermal patch | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
739 | Exelon 9.5 mg/24 h transdermal patch | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
740 | Exelon Patch | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
741 | Exelon Patch (rivastigmine transdermal system) | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
742 | Exelon path transdermal | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
743 | Exelon ® | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
744 | EXENATIDE | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 6件: 6 6, 17, 72, 78, 193, 233 |
745 | Exenatide 10 micrograms | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
746 | Exenatide 5 micrograms | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
747 | Exenatide extended release 2mg (Bydureon) | 1件: Exenatide Exenatide | 1件: D04121
D04121
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
748 | Exergame | - | - | - | - | 2件: 6 6, 13 |
749 | EXN-32 | - | - | - | - | 1件: 6 6 |
750 | EXN-32 (CARBIDOPA E LEVODOPA) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
751 | EXN-44 | - | - | - | - | 1件: 6 6 |
752 | EXN-44(LEVODOPA) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
753 | F-18 FPCIT | - | - | - | - | 1件: 6 6 |
754 | Famotidine | 1件: Famotidine Famotidine | 1件: D00318
D00318
| 1件: HRH2 HRH2 💬 | 3件: Calcium signaling pathway Calcium signaling pathway, Gastric acid secretion, Neuroactive ligand-receptor interaction 💬 | 6件: 6 6, 46, 86, 98, 107, 300 |
755 | FB-101 | - | - | - | - | 1件: 6 6 |
756 | Febuxostat | 1件: Febuxostat Febuxostat | 1件: D01206
D01206
| 1件: XDH XDH 💬 | 5件: Caffeine metabolism Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism 💬 | 3件: 2 2, 6, 13 |
757 | Ferriprox | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 2件: 6 6, 120 |
758 | Ferriprox 500 mg | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
759 | Ferrprox (Deferiprone) | 1件: Deferiprone Deferiprone | 1件: D07416
D07416
| - | - | 1件: 6 6 |
760 | Fesoterodine | 1件: Fesoterodine Fesoterodine | 1件: D07226
D07226
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
761 | Fetal porcine cells, Neurocell-PD | - | - | - | - | 1件: 6 6 |
762 | Filgrastim | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 28件: 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 |
763 | Finamine tablets | - | - | - | - | 1件: 6 6 |
764 | Finasteride | 1件: Finasteride Finasteride | 1件: D00321
D00321
| 1件: SRD5A2 SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 |
765 | Fipamezole | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
766 | Fipamezole hydrochloride | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
767 | Fipamezole hydrochloride 30 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
768 | Fipamezole hydrochloride 60 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
769 | Fipamezole hydrochloride 90 mg oral disintegrating tablets | 1件: Fipamezole Fipamezole | - | - | - | 2件: 6 6, 17 |
770 | Fipamezole ODT | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 |
771 | Fipamezole ODT Cohort 2 | 1件: Fipamezole Fipamezole | - | - | - | 1件: 6 6 |
772 | Flecainide | 1件: Flecainide Flecainide | 2件: D00638
D00638
,
D07962
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
773 | FLECAINIDE ACETATE | 2件: Acetate Acetate, Flecainide | 2件: D00638
D00638
,
D07962
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
774 | Flecainidum | 1件: Flecainide Flecainide | 2件: D00638
D00638
,
D07962
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
775 | FLORBETABEN (18F) | 1件: Florbetaben (18F) Florbetaben (18F) | - | - | - | 1件: 6 6 |
776 | Florbetapir F 18 | - | - | - | - | 1件: 6 6 |
777 | Fludrocortisone | 1件: Fludrocortisone Fludrocortisone | 2件: D00986
D00986
,
D07967
| 1件: NR3C2 NR3C2 💬 | 1件: Aldosterone-regulated sodium reabsorption Aldosterone-regulated sodium reabsorption 💬 | 3件: 6 6, 17, 81 |
778 | Flumazenil | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
779 | Fluoroscopic swallow evaluation | - | - | - | - | 1件: 6 6 |
780 | Flutemetamol | 1件: Flutemetamol (18F) Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
781 | Flutemetamol F18 | 2件: Flutemetamol Flutemetamol, Flutemetamol (18F) | - | - | - | 5件: 5 5, 6, 7, 17, 127 |
782 | Folic acid | 1件: Folic acid Folic acid | 1件: D00070
D00070
| - | - | 4件: 6 6, 46, 49, 84 |
783 | Folic Acid, Vitamin B6, Vitamin B12 | 3件: Cyanocobalamin Cyanocobalamin, Folic acid, Pyridoxine | 7件: D00070
D00070
,
D00166
,
D02179
,
D03615
,
D03616
,
D03617
,
D08454
| - | - | 1件: 6 6 |
784 | Foliglurax | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
785 | Foliglurax 10 mg (treatment A) | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
786 | Foliglurax 30 mg (treatment B) | 1件: Foliglurax Foliglurax | - | - | - | 1件: 6 6 |
787 | Foscarbidopa | 1件: Foscarbidopa Foscarbidopa | 1件: D12057
D12057
| - | - | 1件: 6 6 |
788 | Foscarbidopa and Foslevodopa | 2件: Foscarbidopa Foscarbidopa, Foslevodopa | 2件: D11839
D11839
,
D12057
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
789 | Foslevodopa | 1件: Foslevodopa Foslevodopa | 1件: D11839
D11839
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
790 | FPF1100NW | - | - | - | - | 1件: 6 6 |
791 | FPFS-1169 | - | - | - | - | 1件: 6 6 |
792 | Functional Magnetic Resonance Imaging | - | - | - | - | 1件: 6 6 |
793 | Furosemide | 1件: Furosemide Furosemide | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
794 | Furosemide Injection | 1件: Furosemide Furosemide | 1件: D00331
D00331
| 1件: SLC12A2 SLC12A2 💬 | 3件: Pancreatic secretion Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬 | 1件: 6 6 |
795 | G-CSF | 1件: Filgrastim Filgrastim | 1件: D03235
D03235
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 16件: 2 2, 6, 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 |
796 | GABAPENTIN | 1件: Gabapentin Gabapentin | 1件: D00332
D00332
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 5件: 6 6, 13, 19, 70, 298 |
797 | GABAPENTINA | 1件: Gabapentin Gabapentin | 1件: D00332
D00332
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 6 6 |
798 | GABAPENTINA KERN PHARMA | 1件: Gabapentin Gabapentin | 1件: D00332
D00332
| 5件: CACNA2D1 CACNA2D1, CACNA2D2, CACNA2D3, CACNA2D4, SLC6A1 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, GABAergic synapse, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway, Synaptic vesicle cycle 💬 | 1件: 6 6 |
799 | GALANTAMINE | 1件: Galantamine Galantamine | 2件: D02173
D02173
,
D04292
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 127 |
800 | Galantamine hydrobromide | 1件: Galantamine Galantamine | 2件: D02173
D02173
,
D04292
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 127 |
801 | Ganoderma | - | - | - | - | 1件: 6 6 |
802 | GE180 PET Scan | - | - | - | - | 1件: 6 6 |
803 | Genetic: Optional pharmacogenetic assessment | - | - | - | - | 1件: 6 6 |
804 | GENZ-682452 | 1件: Venglustat Venglustat | 1件: D11633
D11633
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 6 6, 19, 67 |
805 | Genz-682452-AU | 1件: Venglustat Venglustat | 1件: D11633
D11633
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 6 6, 19, 67 |
806 | Ghrelin | 1件: Lenomorelin Lenomorelin | - | - | - | 6件: 6 6, 78, 193, 201, 202, 299 |
807 | Ginkgo | 1件: Ginkgo biloba Ginkgo biloba | - | - | - | 5件: 6 6, 13, 18, 47, 90 |
808 | Glial cell line-derived neurotrophic factor | - | - | - | - | 1件: 6 6 |
809 | Glial Cell Line-Derived Neurotrophic Factor (GDNF) | - | - | - | - | 1件: 6 6 |
810 | Glucose | 1件: Dextrose, unspecified form Dextrose, unspecified form | - | - | - | 15件: 2 2, 6, 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 |
811 | Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
812 | Glycerol | 1件: Glycerin Glycerin | 1件: D00028
D00028
| - | - | 5件: 6 6, 13, 79, 316, 317 |
813 | Glycerol Phenylbutyrate | 3件: Glycerin Glycerin, Glycerol phenylbutyrate, Phenylbutyric acid | 2件: D00028
D00028
,
D10127
| - | - | 1件: 6 6 |
814 | Glycopyrrolate | - | - | - | - | 2件: 6 6, 34 |
815 | GM1 ganglioside | - | - | - | - | 1件: 6 6 |
816 | GM608 | - | - | - | - | 1件: 6 6 |
817 | GOCOVRI | - | - | - | - | 1件: 6 6 |
818 | Gold | 1件: Gold Gold | - | - | - | 43件: 2 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318 |
819 | Gold Nanocrystals | - | - | - | - | 3件: 2 2, 6, 13 |
820 | GPI 1485 | - | - | - | - | 1件: 6 6 |
821 | Grapefruit | 1件: Grapefruit Grapefruit | - | - | - | 5件: 6 6, 46, 50, 83, 97 |
822 | Green Tea | 1件: Green tea leaf Green tea leaf | 1件: D06903
D06903
| - | - | 5件: 6 6, 17, 28, 46, 96 |
823 | Green Tea Polyphenols (EGCG/ECG) | 2件: Epigallocatechin gallate Epigallocatechin gallate, Green tea leaf | 1件: D06903
D06903
| - | - | 1件: 6 6 |
824 | GRF6021 | - | - | - | - | 1件: 6 6 |
825 | Group AD Anti-PD + Antidepressant | - | - | - | - | 1件: 6 6 |
826 | Group R Rasagiline | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
827 | Group R+AD Rasagiline + Antidepressant | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
828 | GSH | - | - | - | - | 2件: 6 6, 299 |
829 | GSK962040 | - | - | - | - | 1件: 6 6 |
830 | GSK962040 (25 mg tablet) | - | - | - | - | 1件: 6 6 |
831 | Guar gum | 1件: Guar gum Guar gum | 1件: D04403
D04403
| - | - | 1件: 6 6 |
832 | HA 1A ANTICORPO MONOCLONALE UMANO CLASSE IGM | - | - | - | - | 2件: 6 6, 49 |
833 | HB-adMSCs | 1件: Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins Adipose-Derived Mesenchymal Stem Cells: Autologous or Allogeneic Origins | - | - | - | 7件: 2 2, 4, 6, 13, 46, 49, 113 |
834 | HEC122505MsOH | - | - | - | - | 1件: 6 6 |
835 | Helicobacter pylori eradication therapy | - | - | - | - | 1件: 6 6 |
836 | Heptaminol | 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
837 | Heptaminol hydrochloride | 1件: Heptaminol Heptaminol | 1件: D07158
D07158
| - | - | 1件: 6 6 |
838 | Herbal Medicinal Mixture (Roucongrong, Heshouwu etc.) | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
839 | Hericium erinaceus mycelium | - | - | - | - | 1件: 6 6 |
840 | Heshouwu | 1件: Reynoutria multiflora root Reynoutria multiflora root | - | - | - | 1件: 6 6 |
841 | HF0220 | - | - | - | - | 1件: 6 6 |
842 | High dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 |
843 | High dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 |
844 | High dose levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
845 | High Protein. T-Diet plus Range | - | - | - | - | 1件: 6 6 |
846 | High-Frequency-Only Stimulation | - | - | - | - | 1件: 6 6 |
847 | Home based balance training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 2件: 6 6, 13 |
848 | HP-3000 (ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
849 | HP-3000 placebo | - | - | - | - | 1件: 6 6 |
850 | HP-3000(ropinirole hydrochloride patch) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
851 | Human Amniotic Epithelial Stem Cells | - | - | - | - | 1件: 6 6 |
852 | Human neural stem cell | - | - | - | - | 1件: 6 6 |
853 | Human Stem Cells | - | - | - | - | 1件: 6 6 |
854 | Hydrocortisone | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 10件: 6 6, 41, 46, 53, 75, 78, 81, 83, 97, 299 |
855 | Hydrocortisone cream | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
856 | Hydrocortisone cream 1% | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
857 | Hydrocortisone cream 10mg/g FNA Fagron | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
858 | Hydrogen | 1件: Hydrogen Hydrogen | - | - | - | 7件: 5 5, 6, 13, 17, 83, 97, 226 |
859 | Hydrolyzed guar gum | 1件: Guar gum Guar gum | 1件: D04403
D04403
| - | - | 1件: 6 6 |
860 | Hypoestoxide | - | - | - | - | 1件: 6 6 |
861 | Hypoxic Gas Mixture | - | - | - | - | 1件: 6 6 |
862 | I 123 | 1件: Iodide I-123 Iodide I-123 | - | - | - | 1件: 6 6 |
863 | I-123 | 1件: Iodide I-123 Iodide I-123 | - | - | - | 2件: 2 2, 6 |
864 | I-123-5-IA85380 | 1件: Iodide I-123 Iodide I-123 | - | - | - | 1件: 6 6 |
865 | I123 | - | - | - | - | 1件: 6 6 |
866 | IBEROGAST | - | - | - | - | 1件: 6 6 |
867 | Idebenone | 1件: Idebenone Idebenone | 1件: D01750
D01750
| - | - | 6件: 6 6, 8, 13, 18, 113, 302 |
868 | IkT-148009 | - | - | - | - | 1件: 6 6 |
869 | Immediate release carbidopa/levodopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
870 | Immediate Release carbidopa/levodopa 10/100 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
871 | Immediate Release carbidopa/levodopa 25/100 mg | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
872 | Impact | - | - | - | - | 8件: 6 6, 13, 46, 50, 53, 96, 97, 299 |
873 | Inbrija | - | - | - | - | 1件: 6 6 |
874 | Incobotulinum Toxin A | - | - | - | - | 3件: 2 2, 6, 13 |
875 | IncobotulinumtoxinA | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
876 | IncobotulinumtoxinA (100 Units) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
877 | IncobotulinumtoxinA (75 Units) | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
878 | Infudopa i.v. | - | - | - | - | 1件: 6 6 |
879 | Infudopa s.c. | - | - | - | - | 1件: 6 6 |
880 | Infusion Pump: CADD-Legacy® 1400 Pump | - | - | - | - | 1件: 6 6 |
881 | Infusions of young plasma | - | - | - | - | 1件: 6 6 |
882 | Inhaled VR040 | - | - | - | - | 1件: 6 6 |
883 | Injection of apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
884 | Injection of normal saline | - | - | - | - | 1件: 6 6 |
885 | Injection of Umbilical cord derived MSCs | - | - | - | - | 1件: 6 6 |
886 | Inosine | 1件: Inosine Inosine | 1件: D00054
D00054
| - | - | 5件: 2 2, 6, 13, 17, 122 |
887 | INS-GSH | - | - | - | - | 1件: 6 6 |
888 | Inspiratory Muscle Training | - | - | - | - | 1件: 6 6 |
889 | Insulin | - | - | - | - | 6件: 6 6, 13, 46, 75, 78, 299 |
890 | Intracerebral microinjections | - | - | - | - | 1件: 6 6 |
891 | Intranasal glutathione - (in)GSH | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 6 6 |
892 | Intranasal Insulin | - | - | - | - | 2件: 6 6, 17 |
893 | Intravenous and Oral n-acetyl cysteine | 1件: Cysteine Cysteine | 2件: D00026
D00026
,
D02326
| - | - | 1件: 6 6 |
894 | Intravenous Infusion | - | - | - | - | 1件: 6 6 |
895 | Intravenous Levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
896 | Intravesical injection of Botulinum A toxin | - | - | - | - | 2件: 6 6, 17 |
897 | IODIO IOFLUPANO-123I | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
898 | Ioflupane | - | - | - | - | 1件: 6 6 |
899 | IOFLUPANE (123I) | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
900 | Ioflupane 123I (DATSCAN®) | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
901 | Ioflupane [123 I] | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
902 | Ioflupane [123I] | 1件: Ioflupane I-123 Ioflupane I-123 | - | - | - | 1件: 6 6 |
903 | Ioflupane I 123 | 2件: Iodide I-123 Iodide I-123, Ioflupane I-123 | - | - | - | 1件: 6 6 |
904 | Ipratropium | 1件: Ipratropium Ipratropium | 1件: D02212
D02212
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 86 |
905 | Ipratropium bromide (drug) | 1件: Ipratropium Ipratropium | 1件: D02212
D02212
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
906 | IPRONIAZID | 1件: Iproniazid Iproniazid | 1件: D02579
D02579
| 2件: MAOA MAOA, MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
907 | Ips-nsc cells | - | - | - | - | 1件: 6 6 |
908 | IPT803 | - | - | - | - | 1件: 6 6 |
909 | IPX054 100 mg | - | - | - | - | 1件: 6 6 |
910 | IPX054 150 mg | - | - | - | - | 1件: 6 6 |
911 | IPX054 200 mg | - | - | - | - | 1件: 6 6 |
912 | IPX054 250 mg | - | - | - | - | 1件: 6 6 |
913 | IPX054 300 mg | - | - | - | - | 1件: 6 6 |
914 | IPX066 | - | - | - | - | 1件: 6 6 |
915 | IPX066 145 mg | - | - | - | - | 1件: 6 6 |
916 | IPX066 145 mg LD | - | - | - | - | 1件: 6 6 |
917 | IPX066 195 mg | - | - | - | - | 1件: 6 6 |
918 | IPX066 195 mg LD | - | - | - | - | 1件: 6 6 |
919 | IPX066 245 mg | - | - | - | - | 1件: 6 6 |
920 | IPX066 245 mg LD | - | - | - | - | 1件: 6 6 |
921 | IPX066 95 mg | - | - | - | - | 1件: 6 6 |
922 | IPX066 95 mg LD | - | - | - | - | 1件: 6 6 |
923 | IPX066-145 | - | - | - | - | 1件: 6 6 |
924 | IPX066-195 | - | - | - | - | 1件: 6 6 |
925 | IPX066-245 | - | - | - | - | 1件: 6 6 |
926 | IPX066-95 | - | - | - | - | 1件: 6 6 |
927 | IPX203 | - | - | - | - | 1件: 6 6 |
928 | IPX203 140 mg | - | - | - | - | 1件: 6 6 |
929 | IPX203 180 mg | - | - | - | - | 1件: 6 6 |
930 | IPX203 210 mg | - | - | - | - | 1件: 6 6 |
931 | IPX203 270 mg | - | - | - | - | 1件: 6 6 |
932 | IPX203 280 mg | - | - | - | - | 1件: 6 6 |
933 | IPX203 350 mg | - | - | - | - | 1件: 6 6 |
934 | IPX203 ER CD-LD | - | - | - | - | 1件: 6 6 |
935 | IR CD-LD | - | - | - | - | 1件: 6 6 |
936 | IR CD-LD (carbidopa-levodopa) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
937 | IR LD / CD | - | - | - | - | 1件: 6 6 |
938 | IR LD/CD | - | - | - | - | 1件: 6 6 |
939 | IRL752 | - | - | - | - | 1件: 6 6 |
940 | IRL790 | - | - | - | - | 1件: 6 6 |
941 | IRX4204 | - | - | - | - | 1件: 6 6 |
942 | ISC-hpNSC | - | - | - | - | 1件: 6 6 |
943 | Isicom | - | - | - | - | 1件: 6 6 |
944 | Isoflurane | 1件: Isoflurane Isoflurane | 1件: D00545
D00545
| - | - | 1件: 6 6 |
945 | Isradipine | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
946 | Isradipine CR 10mg | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
947 | Isradipine CR 20mg | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
948 | Isradipine CR 5mg | 1件: Isradipine Isradipine | 1件: D00349
D00349
| 4件: CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | 37件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
949 | ISTRADEFYLLINE | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
950 | Istradefylline ( KW-6002) | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
951 | Istradefylline (KW-6002) | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
952 | Istradefylline 20 mg | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
953 | Istradefylline 20 mg or 40 mg | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
954 | Istradefylline 40 mg | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
955 | ITI-214 | 1件: ITI-214 ITI-214 | - | - | - | 1件: 6 6 |
956 | IV Apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
957 | IV Levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
958 | IZD174 | - | - | - | - | 2件: 6 6, 106 |
959 | J-tube | - | - | - | - | 1件: 6 6 |
960 | Jejunal extension tube | - | - | - | - | 1件: 6 6 |
961 | Jejunal extension tube (J-tube) | - | - | - | - | 1件: 6 6 |
962 | JM | - | - | - | - | 2件: 6 6, 13 |
963 | JM-010 | - | - | - | - | 1件: 6 6 |
964 | JM-010 group A | - | - | - | - | 1件: 6 6 |
965 | JM-010 group B | - | - | - | - | 1件: 6 6 |
966 | JNJ-31001074 | - | - | - | - | 1件: 6 6 |
967 | JNJ31-31001074 | - | - | - | - | 1件: 6 6 |
968 | JP 1730 | - | - | - | - | 1件: 6 6 |
969 | JP-1730/F01 | - | - | - | - | 2件: 6 6, 17 |
970 | JP-1730/F02 | - | - | - | - | 2件: 6 6, 17 |
971 | JP-1730/F03 | - | - | - | - | 2件: 6 6, 17 |
972 | Juvit D3 | - | - | - | - | 1件: 6 6 |
973 | JZP-110 | - | - | - | - | 1件: 6 6 |
974 | K0706 | - | - | - | - | 1件: 6 6 |
975 | KDT-3594 | - | - | - | - | 1件: 6 6 |
976 | KETAMINE | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 6件: 6 6, 13, 70, 113, 156, 215 |
977 | Ketamine Infusion | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
978 | Ketone ester drink | - | - | - | - | 1件: 6 6 |
979 | Ketone Ester Elite endurance Nutrition Drink | - | - | - | - | 1件: 6 6 |
980 | Kinetra and Soletra (neurostimulator, Medtronic) | - | - | - | - | 1件: 6 6 |
981 | Kinoquinone (proposed) | - | - | - | - | 1件: 6 6 |
982 | KM-819 | - | - | - | - | 1件: 6 6 |
983 | KW-6002 | - | - | - | - | 1件: 6 6 |
984 | KW-6002 (istradefylline) | 1件: Istradefylline Istradefylline | 1件: D04641
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
985 | KW-6356 | - | - | - | - | 1件: 6 6 |
986 | KW-6356 High Dose | - | - | - | - | 1件: 6 6 |
987 | KW-6356 Low Dose | - | - | - | - | 1件: 6 6 |
988 | KW-6356 Middle Dose | - | - | - | - | 1件: 6 6 |
989 | KW-6356 X Dose | - | - | - | - | 1件: 6 6 |
990 | KW-6356 Y Dose | - | - | - | - | 1件: 6 6 |
991 | KW-6500 | - | - | - | - | 1件: 6 6 |
992 | L-123 Ioflupane | - | - | - | - | 1件: 6 6 |
993 | L-3-(3,4-Dihydroxyphenyl)alanine | 1件: Alanine Alanine | 1件: D00012
D00012
| - | - | 1件: 6 6 |
994 | L-DOPA | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
995 | L-Dopa/ MODOPAR | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
996 | L-DOPA/DDCI | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
997 | L-DOPS | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
998 | L-methylfolate | 1件: Levomefolic acid Levomefolic acid | 1件: D09353
D09353
| - | - | 1件: 6 6 |
999 | L-tyrosine | 1件: Tyrosine Tyrosine | 1件: D00022
D00022
| - | - | 2件: 6 6, 111 |
1000 | LA | - | - | - | - | 5件: 6 6, 13, 75, 76, 222 |
1001 | Lactobacillus | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 5件: 6 6, 46, 51, 97, 299 |
1002 | Lactobacillus casei | 1件: Lactobacillus casei Lactobacillus casei | 1件: D04351
D04351
| - | - | 3件: 6 6, 97, 296 |
1003 | Lactobacillus casei DG (Enterolactis duo®) | 1件: Lactobacillus casei Lactobacillus casei | 1件: D04351
D04351
| - | - | 1件: 6 6 |
1004 | Lactobacillus plantarum | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 3件: 6 6, 97, 156 |
1005 | Lactobacillus plantarum PS128 | 1件: Lactobacillus plantarum Lactobacillus plantarum | - | - | - | 1件: 6 6 |
1006 | Lactose | 1件: Lactose Lactose | 2件: D00046
D00046
,
D03226
| - | - | 6件: 2 2, 6, 13, 97, 228, 310 |
1007 | LCIG | - | - | - | - | 1件: 6 6 |
1008 | LCIG (Duodopa) | - | - | - | - | 1件: 6 6 |
1009 | LD / BE | - | - | - | - | 1件: 6 6 |
1010 | LD+DDCI | - | - | - | - | 1件: 6 6 |
1011 | LD-DDCI | - | - | - | - | 1件: 6 6 |
1012 | LD/CD | - | - | - | - | 1件: 6 6 |
1013 | Leptin | 1件: Leptin Leptin | - | - | - | 2件: 6 6, 265 |
1014 | Leucine | 1件: Leucine Leucine | 1件: D00030
D00030
| - | - | 11件: 5 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299 |
1015 | Levetiracetam | 1件: Levetiracetam Levetiracetam | 1件: D00709
D00709
| 1件: SV2A SV2A 💬 | 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 |
1016 | Levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 8件: 2 2, 4, 6, 17, 90, 140, 164, 201 |
1017 | LEVODOPA (DC.IT) (FU) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1018 | Levodopa (delivered intravenously) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1019 | Levodopa (drug), intraduodenal administration | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1020 | Levodopa (L-dopa) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1021 | Levodopa (L-DOPA) + Standard care | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1022 | LEVODOPA (LD) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1023 | Levodopa / Benserazid | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1024 | LEVODOPA / BENSERAZIDE 200 + 50 MG | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1025 | Levodopa 100 mg / benserazide 25 mg | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1026 | Levodopa 100 mg A CAP | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1027 | Levodopa 125 mg A CAP | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1028 | Levodopa 150 mg A CAP | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1029 | Levodopa 25mg/100mg | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1030 | Levodopa 75 mg A CAP | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1031 | Levodopa acute challenge | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1032 | Levodopa and carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1033 | Levodopa and carbidopa SC solution | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1034 | Levodopa and carbidopa solution for SC administration | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1035 | Levodopa and decarboxylase inhibitor | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1036 | Levodopa and Domperidone | 2件: Domperidone Domperidone, Levodopa | 3件: D00059
D00059
,
D01745
,
D07868
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1037 | Levodopa Benserazide Madopar | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1038 | Levodopa Benserazide Teva Italia | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1039 | Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1040 | Levodopa carbidopa intestinal gel (LCIG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1041 | Levodopa CR (controlled release) | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1042 | Levodopa Cyclops | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1043 | LEVODOPA DC.IT FU | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1044 | Levodopa dispersible | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1045 | Levodopa infusion | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1046 | LEVODOPA INN | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1047 | Levodopa MR | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1048 | Levodopa powder for inhalation | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1049 | Levodopa tablet | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1050 | Levodopa, carbidopa, entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1051 | Levodopa, carbidopa, ODM-104 | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1052 | Levodopa, decarboxylase inhibitor and COMT inhibitor | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1053 | Levodopa-4'-Monophosphate | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1054 | Levodopa-Carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 2件: 6 6, 90 |
1055 | Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1056 | Levodopa-carbidopa Immediate Release (LC-IR) Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1057 | Levodopa-Carbidopa Intestinal Gel | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1058 | Levodopa-Carbidopa Intestinal Gel (LCIG) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1059 | Levodopa-Carbidopa Multilayer Extended Release Tablet | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1060 | Levodopa-Carbidopa XL tablet (M) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1061 | Levodopa-carbidopa-entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1062 | Levodopa/benserazide | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1063 | Levodopa/benserazide 100/25 mg | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1064 | LEVODOPA/BENZERASIDE | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1065 | Levodopa/Benzerazide | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1066 | LEVODOPA/CARBIDOPA | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 2件: 6 6, 164 |
1067 | Levodopa/Carbidopa (LD/CD) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1068 | Levodopa/Carbidopa (Sinemet) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1069 | Levodopa/carbidopa 100/25 | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1070 | Levodopa/Carbidopa Hydrate | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1071 | Levodopa/Carbidopa Solution | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1072 | Levodopa/Carbidopa(200mg/50mg) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1073 | Levodopa/carbidopa/entacapone | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1074 | Levodopa/DDCI | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1075 | Levodopa/dopa decarboxylase inhibitor | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1076 | Liatermin | 1件: Liatermin Liatermin | 1件: D04727
D04727
| - | - | 1件: 6 6 |
1077 | Liatermin (r-metHuGDNF) | 1件: Liatermin Liatermin | 1件: D04727
D04727
| - | - | 1件: 6 6 |
1078 | Lidocaine | 1件: Lidocaine Lidocaine | 3件: D00358
D00358
,
D02086
,
D08127
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 12件: 6 6, 13, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256 |
1079 | Light box ( Litebook company) | - | - | - | - | 1件: 6 6 |
1080 | Light box (Litebook company) | - | - | - | - | 1件: 6 6 |
1081 | Linaclotide | 1件: Linaclotide Linaclotide | 1件: D09355
D09355
| 1件: GUCY2C GUCY2C 💬 | 2件: Metabolic pathways Metabolic pathways, Purine metabolism 💬 | 2件: 6 6, 97 |
1082 | Lingzhi (Ganoderma) | - | - | - | - | 1件: 6 6 |
1083 | Lipopolysaccharide | - | - | - | - | 1件: 6 6 |
1084 | Lipuro | - | - | - | - | 1件: 6 6 |
1085 | Liquigen MCT oil | - | - | - | - | 1件: 6 6 |
1086 | Liraglutide | 1件: Liraglutide Liraglutide | 1件: D06404
D06404
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 3件: 6 6, 75, 193 |
1087 | Lisparin | - | - | - | - | 1件: 6 6 |
1088 | LISURIDE | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 86 |
1089 | Lisuride Hydrogenmaleate | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1090 | Lisuride Transdermal System | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1091 | Lisuride TTS | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1092 | Lisuride TTS 10cm² | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1093 | Lisuride TTS 20cm² | 1件: Lisuride Lisuride | 2件: D01462
D01462
,
D08132
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1094 | Lithium | 1件: Lithium citrate Lithium citrate | 1件: D04749
D04749
| - | - | 5件: 2 2, 5, 6, 7, 8 |
1095 | Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules | 1件: Lactobacillus delbrueckii bulgaricus Lactobacillus delbrueckii bulgaricus | - | - | - | 1件: 6 6 |
1096 | Lixisenatide | 1件: Lixisenatide Lixisenatide | 1件: D09729
D09729
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
1097 | Local Anesthesia (lidocaine hydrochloride) | 1件: Lidocaine Lidocaine | 3件: D00358
D00358
,
D02086
,
D08127
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
1098 | Local Trade Name, 2mg | - | - | - | - | 1件: 6 6 |
1099 | Local Trade Name, 4mg | - | - | - | - | 1件: 6 6 |
1100 | Local Trade Name, 8mg | - | - | - | - | 1件: 6 6 |
1101 | LODALÈS® | - | - | - | - | 1件: 6 6 |
1102 | Lovastatin | 1件: Lovastatin Lovastatin | 1件: D00359
D00359
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 |
1103 | Low dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | 1件: 6 6 |
1104 | Low dose levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1105 | Low-Frequency-Only Stimulation | - | - | - | - | 1件: 6 6 |
1106 | Lu 00-800 | - | - | - | - | 1件: 6 6 |
1107 | Lu AF28996 | - | - | - | - | 1件: 6 6 |
1108 | Lu AF82422 | - | - | - | - | 2件: 6 6, 17 |
1109 | LUBIPROSTONE | 1件: Lubiprostone Lubiprostone | 1件: D04790
D04790
| 1件: CLCN2 CLCN2 💬 | 1件: Mineral absorption Mineral absorption 💬 | 4件: 6 6, 13, 290, 299 |
1110 | Lumbar Puncture | - | - | - | - | 6件: 6 6, 13, 19, 96, 97, 127 |
1111 | LY03003 | - | - | - | - | 1件: 6 6 |
1112 | LY03003 ( Rotigotine, extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1113 | LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1114 | LY03003( the name of rotigotine) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1115 | LY03003(Rotigotine,extended-release microspheres) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1116 | LY03009 F1 | - | - | - | - | 1件: 6 6 |
1117 | LY03009 F2 | - | - | - | - | 1件: 6 6 |
1118 | LY03009 F3 | - | - | - | - | 1件: 6 6 |
1119 | LY03009 F4 | - | - | - | - | 1件: 6 6 |
1120 | LY300164 | - | - | - | - | 1件: 6 6 |
1121 | LY3154207 | - | - | - | - | 1件: 6 6 |
1122 | Madopar | - | - | - | - | 1件: 6 6 |
1123 | Madopar 125 mg T, tablets | - | - | - | - | 1件: 6 6 |
1124 | Madopar 125 mg, orodispersible tablet | - | - | - | - | 1件: 6 6 |
1125 | Madopar 200+50 mg | - | - | - | - | 1件: 6 6 |
1126 | Madopar LT | - | - | - | - | 1件: 6 6 |
1127 | Madopar monotherapy | - | - | - | - | 1件: 6 6 |
1128 | Madopar Tab. 125 or Perkin Tab. 25-100mg | - | - | - | - | 1件: 6 6 |
1129 | Madopar® 125 | - | - | - | - | 1件: 6 6 |
1130 | Madopar® 125 mg T Tablets Levodopa 100 mg Benserazide 25 mg (as benserazide hydrochloride) | 2件: Benserazide Benserazide, Levodopa | 2件: D00059
D00059
,
D03082
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1131 | Madopar® 250 | - | - | - | - | 1件: 6 6 |
1132 | Madopar® HBS | - | - | - | - | 1件: 6 6 |
1133 | Madopar® HBS 125 | - | - | - | - | 1件: 6 6 |
1134 | Magnesium | 1件: Magnesium Magnesium | - | - | - | 19件: 3 3, 6, 11, 13, 15, 46, 64, 70, 93, 97, 166, 225, 235, 256, 284, 291, 296, 297, 298 |
1135 | Magnesium oxide | 2件: Magnesium Magnesium, Magnesium oxide | 1件: D01167
D01167
| - | - | 3件: 6 6, 166, 291 |
1136 | Magnetic Resonance Imaging | - | - | - | - | 7件: 6 6, 13, 19, 22, 34, 205, 299 |
1137 | Maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: D02329
D02329
| - | - | 4件: 6 6, 13, 96, 97 |
1138 | Mannitol | 1件: Mannitol Mannitol | 1件: D00062
D00062
| - | - | 7件: 6 6, 13, 28, 60, 96, 113, 299 |
1139 | MANTADIX | - | - | - | - | 1件: 6 6 |
1140 | MARS | - | - | - | - | 1件: 6 6 |
1141 | MASITINIB | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
1142 | MASITINIB MESYLATE | 1件: Masitinib Masitinib | 1件: D10229
D10229
| 1件: KIT KIT 💬 | 11件: Acute myeloid leukemia Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway 💬 | 6件: 2 2, 5, 6, 13, 46, 96 |
1143 | Massage with a spiky ball | - | - | - | - | 1件: 6 6 |
1144 | Mavoglurant | 1件: Mavoglurant Mavoglurant | - | - | - | 2件: 6 6, 206 |
1145 | MCT | - | - | - | - | 2件: 6 6, 296 |
1146 | ME2125 (safinamide mesilate) | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1147 | MEDI1341 | - | - | - | - | 1件: 6 6 |
1148 | Medical Cannabis | 1件: Medical Cannabis Medical Cannabis | - | - | - | 1件: 6 6 |
1149 | MEG | - | - | - | - | 1件: 6 6 |
1150 | Melatonin | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 12件: 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
1151 | Melatonin PR | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1152 | Melatonin(Circadin®) | 1件: Melatonin Melatonin | 1件: D08170
D08170
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1153 | Melevodopa | 1件: Melevodopa Melevodopa | 1件: D07304
D07304
| - | - | 1件: 6 6 |
1154 | Melevodopa and decarboxylase inhibitor | 1件: Melevodopa Melevodopa | 1件: D07304
D07304
| - | - | 1件: 6 6 |
1155 | Melperon | - | - | - | - | 1件: 6 6 |
1156 | Melperone | 1件: Melperone Melperone | 1件: D07309
D07309
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1157 | Melperone HCl | 1件: Melperone Melperone | 1件: D07309
D07309
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1158 | Memantin Orion | - | - | - | - | 1件: 6 6 |
1159 | Memantine | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 7件: 2 2, 6, 8, 13, 49, 127, 205 |
1160 | Memantine (drug) | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
1161 | MEMANTINE HYDROCHLORIDE | 1件: Memantine Memantine | 2件: D04905
D04905
,
D08174
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 3件: 2 2, 6, 127 |
1162 | Mesdopetam | 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 |
1163 | Mesdopetam (IRL790) | 1件: Mesdopetam Mesdopetam | - | - | - | 1件: 6 6 |
1164 | Mesencephalic Neuronal Precursor Cells | - | - | - | - | 1件: 6 6 |
1165 | Mesenchymal stem cells | - | - | - | - | 11件: 2 2, 6, 13, 20, 49, 51, 60, 96, 222, 274, 299 |
1166 | Mestinon | 1件: Pyridostigmine Pyridostigmine | 1件: D00487
D00487
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 3 3, 6, 11 |
1167 | Metabolic Cofactor Supplementation | - | - | - | - | 1件: 6 6 |
1168 | Metformin | 1件: Metformin Metformin | 2件: D00944
D00944
,
D04966
| 2件: PRKAA1 PRKAA1, PRKAA2 💬 | 20件: AMPK signaling pathway AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬 | 24件: 2 2, 6, 8, 13, 46, 49, 60, 65, 67, 75, 77, 81, 86, 97, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 |
1169 | Methylphenidate | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 7件: 6 6, 13, 34, 84, 113, 179, 206 |
1170 | Methylphenidate (MPD) | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 1件: 6 6 |
1171 | METHYLPHENIDATE HYDROCHLORIDE | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
1172 | Methylprednisolone | 1件: Methylprednisolone Methylprednisolone | 6件: D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
1173 | Mg | - | - | - | - | 4件: 6 6, 13, 51, 111 |
1174 | Mid dose ANAVEX2-73 | - | - | - | - | 1件: 6 6 |
1175 | Midazolam | 1件: Midazolam Midazolam | 3件: D00550
D00550
,
D00696
,
D05028
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 12件: 2 2, 3, 6, 13, 21, 46, 70, 96, 97, 231, 272, 298 |
1176 | Midodrine | 1件: Midodrine Midodrine | 2件: D01307
D01307
,
D08220
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 3件: 6 6, 17, 58 |
1177 | Minocycline | 1件: Minocycline Minocycline | 2件: D00850
D00850
,
D05045
| - | - | 13件: 2 2, 6, 8, 13, 46, 85, 90, 94, 162, 201, 206, 280, 299 |
1178 | Minodronic acid | 1件: Minodronic acid Minodronic acid | - | - | - | 4件: 6 6, 46, 93, 95 |
1179 | Mirabegron | 1件: Mirabegron Mirabegron | 1件: D09535
D09535
| 1件: ADRB3 ADRB3 💬 | 8件: Calcium signaling pathway Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 13, 53, 226 |
1180 | Mirapex | - | - | - | - | 1件: 6 6 |
1181 | Mirapex (pramipexole) | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1182 | Mirapex ER | - | - | - | - | 1件: 6 6 |
1183 | Mirapex LA | - | - | - | - | 1件: 6 6 |
1184 | Mirapexin | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1185 | Mirapexin / Sifrol | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1186 | Mirapexin extended release various strengths | 2件: Manganese citrate Manganese citrate, Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1187 | MIRAPEXIN*30CPR 0,7MG | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1188 | Mirapexin/Sifrol | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1189 | MitoQ | - | - | - | - | 3件: 6 6, 13, 97 |
1190 | MK0657 | - | - | - | - | 1件: 6 6 |
1191 | MOCLOBEMIDE | 1件: Moclobemide Moclobemide | 1件: D02561
D02561
| 1件: MAOA MAOA 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1192 | MODAFINIL | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 4件: 6 6, 13, 49, 93 |
1193 | Modafinil 50mg | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 1件: 6 6 |
1194 | Modal | - | - | - | - | 5件: 2 2, 6, 17, 46, 70 |
1195 | Modiodal | - | - | - | - | 1件: 6 6 |
1196 | MODOPAR | - | - | - | - | 1件: 6 6 |
1197 | Modopar 125 | - | - | - | - | 1件: 6 6 |
1198 | Modopar 62,5 | - | - | - | - | 1件: 6 6 |
1199 | Monoamine oxidase B inhibitors | - | - | - | - | 1件: 6 6 |
1200 | Montelukast | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 8件: 6 6, 13, 46, 61, 63, 85, 98, 228 |
1201 | Montelukast Krka | 1件: Montelukast Montelukast | 2件: D00529
D00529
,
D08229
| 1件: CYSLTR1 CYSLTR1 💬 | 2件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1202 | MOTILIUM | - | - | - | - | 2件: 6 6, 230 |
1203 | Motion Analysis | - | - | - | - | 1件: 6 6 |
1204 | Moxifloxacin | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 9件: 2 2, 6, 46, 49, 85, 86, 113, 240, 299 |
1205 | Moxifloxacin infusion | 1件: Moxifloxacin Moxifloxacin | 2件: D00874
D00874
,
D08237
| - | - | 1件: 6 6 |
1206 | MS Band 2 | - | - | - | - | 1件: 6 6 |
1207 | MSC | - | - | - | - | 6件: 6 6, 51, 60, 96, 97, 271 |
1208 | MSK-DA01 | - | - | - | - | 1件: 6 6 |
1209 | MSK-DA01 Cell Delivery Device | - | - | - | - | 1件: 6 6 |
1210 | Muscimol | 1件: Muscimol Muscimol | - | - | - | 1件: 6 6 |
1211 | Mémantine | - | - | - | - | 1件: 6 6 |
1212 | N acetyl cysteine | 1件: Cysteine Cysteine | 2件: D00026
D00026
,
D02326
| - | - | 2件: 6 6, 19 |
1213 | N-0923 | - | - | - | - | 1件: 6 6 |
1214 | N-Acetylcysteine | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 11件: 6 6, 13, 19, 20, 49, 58, 85, 111, 164, 299, 337 |
1215 | N-acetylcysteine capsule | 1件: Acetylcysteine Acetylcysteine | 1件: D00221
D00221
| - | - | 1件: 6 6 |
1216 | N.a. | - | - | - | - | 10件: 3 3, 6, 8, 13, 46, 96, 97, 240, 256, 271 |
1217 | N04BA | - | - | - | - | 1件: 6 6 |
1218 | N04BC07 | - | - | - | - | 1件: 6 6 |
1219 | N04BD02 | - | - | - | - | 1件: 6 6 |
1220 | NABILONE | 1件: Nabilone Nabilone | 1件: D05099
D05099
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 2件: 6 6, 13 |
1221 | Nabilone 0.25 mg | 1件: Nabilone Nabilone | 1件: D05099
D05099
| 2件: CNR1 CNR1, CNR2 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | 1件: 6 6 |
1222 | Nacom | - | - | - | - | 1件: 6 6 |
1223 | NACOM 100 | - | - | - | - | 1件: 6 6 |
1224 | NACOM levodopa+cardidopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1225 | Nadolol | 1件: Nadolol Nadolol | 1件: D00432
D00432
| 2件: ADRB1 ADRB1, ADRB2 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1226 | NAL | - | - | - | - | 2件: 6 6, 299 |
1227 | Nalmefene | 1件: Nalmefene Nalmefene | 1件: D05111
D05111
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1228 | Naloxone | 1件: Naloxone Naloxone | 2件: D01340
D01340
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 2件: 6 6, 226 |
1229 | NALOXONE HYDROCHLORIDE DIHYDRATE | 1件: Naloxone Naloxone | 2件: D01340
D01340
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1230 | Naltrexone | 1件: Naltrexone Naltrexone | 2件: D02095
D02095
,
D05113
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 12件: 6 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 |
1231 | Nardil | 1件: Phenelzine Phenelzine | 2件: D00505
D00505
,
D08349
| 2件: MAOA MAOA, MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1232 | NBTX-001 | - | - | - | - | 1件: 6 6 |
1233 | Nd | - | - | - | - | 6件: 2 2, 6, 13, 46, 51, 97 |
1234 | ND0611 | - | - | - | - | 1件: 6 6 |
1235 | ND0612 | - | - | - | - | 1件: 6 6 |
1236 | ND0612 (Levodopa/Carbidopa solution) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1237 | ND1421 | - | - | - | - | 1件: 6 6 |
1238 | ND1587 | - | - | - | - | 1件: 6 6 |
1239 | ND1589 | - | - | - | - | 1件: 6 6 |
1240 | ND1590 | - | - | - | - | 1件: 6 6 |
1241 | ND1702 | - | - | - | - | 1件: 6 6 |
1242 | NE3107 | - | - | - | - | 1件: 6 6 |
1243 | Nebicapone | 1件: Nebicapone Nebicapone | - | - | - | 1件: 6 6 |
1244 | Nebulizer | - | - | - | - | 1件: 6 6 |
1245 | Nelotanserin | 1件: Nelotanserin Nelotanserin | 1件: D09645
D09645
| 1件: HTR2A HTR2A 💬 | 5件: Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | 1件: 6 6 |
1246 | Neridronic Acid | 1件: Neridronic Acid Neridronic Acid | - | - | - | 1件: 6 6 |
1247 | NERIXIA*IM EV 1F 25MG | - | - | - | - | 1件: 6 6 |
1248 | Neu-120 | - | - | - | - | 1件: 6 6 |
1249 | NEUPRO | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1250 | Neupro (Reference) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1251 | NEUPRO 2 mg/24 h parche transdérmico | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1252 | Neupro 2 mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1253 | Neupro 2mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1254 | Neupro 2mg/24h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1255 | NEUPRO 4 mg/24 h parche transdérmico | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1256 | Neupro 4 mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1257 | Neupro 4mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1258 | Neupro 4mg/24h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1259 | Neupro 4Mg/24Hr Transdermal Patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1260 | NEUPRO 6 mg/24 h parche transdérmico | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1261 | Neupro 6 mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1262 | Neupro 6mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1263 | Neupro 6mg/24h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1264 | NEUPRO 8 mg/24 h parche transdérmico | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1265 | Neupro 8 mg/24 h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1266 | Neupro 8mg/24h transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1267 | NEUPRO*28CER 2MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1268 | NEUPRO*28CER 4MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1269 | NEUPRO*28CER 6MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1270 | NEUPRO*28CER 8MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1271 | NEUPRO*7CER 4MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1272 | NEUPRO*7CER 6MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1273 | NEUPRO*7CER 8MG/24H | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1274 | Neupro® | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1275 | Neupro® 8 mg/24 h | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1276 | Neuraceq | 1件: Florbetaben (18F) Florbetaben (18F) | - | - | - | 1件: 6 6 |
1277 | NEUROBLOC | 1件: Botulinum toxin type B Botulinum toxin type B | 1件: D02735
D02735
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 1件: 6 6 |
1278 | NeuroEPO | - | - | - | - | 1件: 6 6 |
1279 | Neurohormonal mechanisms | - | - | - | - | 2件: 6 6, 127 |
1280 | Neurpro | - | - | - | - | 1件: 6 6 |
1281 | Niacin | 1件: Niacin Niacin | 1件: D00049
D00049
| - | - | 3件: 6 6, 78, 265 |
1282 | Niacinamide | 1件: Nicotinamide Nicotinamide | 1件: D00036
D00036
| - | - | 4件: 5 5, 6, 13, 67 |
1283 | Nicorette 10mg/ 16 h | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1284 | Nicorette 15 mg/ 16 h | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1285 | Nicorette 5 mg/ 16 h | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1286 | Nicotinamide | 1件: Nicotinamide Nicotinamide | 1件: D00036
D00036
| - | - | 8件: 2 2, 6, 18, 49, 65, 107, 162, 191 |
1287 | Nicotinamide riboside | 2件: Nicotinamide Nicotinamide, Nicotinamide riboside | 1件: D00036
D00036
| - | - | 4件: 2 2, 6, 18, 191 |
1288 | NICOTINE | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 3件: 6 6, 13, 84 |
1289 | Nicotine gum | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1290 | Nicotine Nasal Spray 10 MG/ML (0.5 MG/SPRAY) | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1291 | Nicotine patch | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 2件: 6 6, 84 |
1292 | Nicotine transdermal patch | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1293 | Nicotinell | - | - | - | - | 1件: 6 6 |
1294 | Nicotinell 17,5 mg/24-Stunden-Pflaster | - | - | - | - | 1件: 6 6 |
1295 | Nicotinell 35 mg/24-Stunden-Pflaster | - | - | - | - | 1件: 6 6 |
1296 | Nilotinib | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 5件: 6 6, 8, 34, 51, 86 |
1297 | Nilotinib 150mg oral capsule [Tasigna] | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
1298 | Nilotinib 300mg oral capsule [Tasigna] | 1件: Nilotinib Nilotinib | 1件: D08953
D08953
| 4件: ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬 | 33件: Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | 1件: 6 6 |
1299 | NITISINONE | 1件: Nitisinone Nitisinone | 1件: D05177
D05177
| 1件: HPD HPD 💬 | 5件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 3件: 6 6, 164, 241 |
1300 | Nitrogen | 1件: Nitrogen Nitrogen | 1件: D00083
D00083
| - | - | 6件: 5 5, 6, 17, 171, 211, 299 |
1301 | NJ-Tube: Silicon ED Tube | 1件: Silicon Silicon | - | - | - | 1件: 6 6 |
1302 | NLX-112 | - | - | - | - | 1件: 6 6 |
1303 | NLY01 | - | - | - | - | 1件: 6 6 |
1304 | NMDA | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
1305 | NO | - | - | - | - | 12件: 6 6, 13, 46, 58, 62, 86, 96, 97, 222, 226, 299, 321 |
1306 | None | - | - | - | - | 16件: 6 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 |
1307 | Normal Saline | - | - | - | - | 18件: 6 6, 13, 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 271, 276, 296, 299 |
1308 | Northera | 1件: Droxidopa Droxidopa | 1件: D01277
D01277
| 9件: ADRA1A ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 | 14件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1309 | Nortriptyline | 1件: Nortriptyline Nortriptyline | 2件: D00816
D00816
,
D08288
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 226 |
1310 | Nortriptyline hydrochloride | 1件: Nortriptyline Nortriptyline | 2件: D00816
D00816
,
D08288
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
1311 | NPC transplantation | - | - | - | - | 1件: 6 6 |
1312 | NR2B NMDA Antagonist CP-101,606 (traxoprodil) | 1件: Ketamine Ketamine | 2件: D00711
D00711
,
D08098
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
1313 | NS 2330 | - | - | - | - | 1件: 6 6 |
1314 | NS2330 | - | - | - | - | 1件: 6 6 |
1315 | NT 101 | - | - | - | - | 4件: 5 5, 6, 7, 17 |
1316 | NTCELL Implantation | - | - | - | - | 1件: 6 6 |
1317 | Null | - | - | - | - | 16件: 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
1318 | NW-1015 | - | - | - | - | 1件: 6 6 |
1319 | NW-1015E, EMD 1195686, MSC2191632B | - | - | - | - | 1件: 6 6 |
1320 | NYX-458 | - | - | - | - | 1件: 6 6 |
1321 | OC oral solution treatment A | - | - | - | - | 1件: 6 6 |
1322 | OC oral solution treatment B | - | - | - | - | 1件: 6 6 |
1323 | OC oral solution treatment C | - | - | - | - | 1件: 6 6 |
1324 | OC oral solution treatment D | - | - | - | - | 1件: 6 6 |
1325 | OCT - TCE | - | - | - | - | 1件: 6 6 |
1326 | ODM-101 | - | - | - | - | 1件: 6 6 |
1327 | ODM-101 105mg Carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1328 | ODM-101 65mg Carbidopa | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1329 | ODM-104 | - | - | - | - | 1件: 6 6 |
1330 | OFF Dopaminergic Medication | - | - | - | - | 1件: 6 6 |
1331 | Omeprazole | 1件: Omeprazole Omeprazole | 4件: D00455
D00455
,
D01207
,
D05259
,
D05261
| 2件: ATP4A ATP4A, ATP4B 💬 | 4件: Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬 | 16件: 6 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 |
1332 | ON Dopaminergic Medication | - | - | - | - | 1件: 6 6 |
1333 | Onabotulinumtoxin A Injection | - | - | - | - | 1件: 6 6 |
1334 | OnabotulinumtoxinA | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 226 |
1335 | Ondansetron | 1件: Ondansetron Ondansetron | 2件: D00456
D00456
,
D00678
| 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 4件: 6 6, 97, 107, 231 |
1336 | Ondansetron 8 mg film-coated tablets | 1件: Ondansetron Ondansetron | 2件: D00456
D00456
,
D00678
| 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
1337 | Ondansetron hydrochloride dihydrate | 1件: Ondansetron Ondansetron | 2件: D00456
D00456
,
D00678
| 5件: HTR3A HTR3A, HTR3B, HTR3C, HTR3D, HTR3E 💬 | 2件: Serotonergic synapse Serotonergic synapse, Taste transduction 💬 | 2件: 6 6, 97 |
1338 | Ongentys | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1339 | Ongentys 50 mg capsule rigide | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1340 | Ongentys 50 mg hard capsules | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1341 | Ongentys 50mg | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1342 | ONO-2160/CD | - | - | - | - | 1件: 6 6 |
1343 | ONO-2370 | - | - | - | - | 1件: 6 6 |
1344 | ONO-2506PO | - | - | - | - | 2件: 2 2, 6 |
1345 | OPC | - | - | - | - | 1件: 6 6 |
1346 | OPICAPONE | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1347 | Opicapone (OPC) | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1348 | Opicapone 50 mg | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1349 | Opicapone 50 mg hard capsules | 1件: Opicapone Opicapone | 1件: D10825
D10825
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1350 | Optimal drug therapy | - | - | - | - | 1件: 6 6 |
1351 | Optimized antiparkinsonian treatment | - | - | - | - | 1件: 6 6 |
1352 | Optimized oral treatment | - | - | - | - | 1件: 6 6 |
1353 | Oral escitalopram | 1件: Escitalopram Escitalopram | 3件: D02567
D02567
,
D07704
,
D07913
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 1件: 6 6 |
1354 | Oral levodopa and carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1355 | Oral Levodopa/Carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1356 | Orally disintegrating selegiline (Zelapar) | 1件: Selegiline Selegiline | 2件: D00785
D00785
,
D03731
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1357 | Orfadin | 1件: Nitisinone Nitisinone | 1件: D05177
D05177
| 1件: HPD HPD 💬 | 5件: Biosynthesis of cofactors Biosynthesis of cofactors, Metabolic pathways, Phenylalanine metabolism, Tyrosine metabolism, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 2件: 6 6, 241 |
1358 | OSU 6162 similar to (-)-OSU 6162 | - | - | - | - | 1件: 6 6 |
1359 | OSU6162 similar to (-)-OSU 6162 | - | - | - | - | 2件: 6 6, 8 |
1360 | OTHER NERVOUS SYSTEM DRUGS | - | - | - | - | 2件: 6 6, 13 |
1361 | Other Parkinson's Disease treatments | - | - | - | - | 1件: 6 6 |
1362 | Other: [11C]donepezil PET | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1363 | Other: Balance | 1件: Isoxaflutole Isoxaflutole | - | - | - | 3件: 6 6, 13, 299 |
1364 | Other: Balance exercise | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1365 | Other: Balance Training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 2件: 6 6, 13 |
1366 | Other: Berg Balance Scale | 1件: Isoxaflutole Isoxaflutole | - | - | - | 2件: 6 6, 13 |
1367 | Other: Best Medical Treatment | - | - | - | - | 1件: 6 6 |
1368 | Other: collection of CSF, blood, urine, saliva | - | - | - | - | 1件: 6 6 |
1369 | Other: Computer game based balance and walking rehabilitation for individuals with Parkinson's Disease | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1370 | Other: Control | - | - | - | - | 9件: 6 6, 19, 67, 70, 75, 85, 97, 162, 193 |
1371 | Other: Controlled environment tests (series of tasks of everyday life) | - | - | - | - | 1件: 6 6 |
1372 | Other: Controls Primary Cervical Dystonia (Trihexyphenidyl) | 1件: Trihexyphenidyl Trihexyphenidyl | 2件: D00787
D00787
,
D08638
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
1373 | Other: Conventional physiotherapy | - | - | - | - | 1件: 6 6 |
1374 | Other: Data Capture | 1件: Bifenthrin Bifenthrin | - | - | - | 1件: 6 6 |
1375 | Other: Diary completion | - | - | - | - | 1件: 6 6 |
1376 | Other: DYT 1 Dystonia | - | - | - | - | 1件: 6 6 |
1377 | Other: DYT 1 Dystonia (Healthy Control) | - | - | - | - | 1件: 6 6 |
1378 | Other: Endurance | - | - | - | - | 1件: 6 6 |
1379 | Other: Evaluation by Investigator | - | - | - | - | 1件: 6 6 |
1380 | Other: Event-related evoked potential using electroencephalography (EEG). | - | - | - | - | 1件: 6 6 |
1381 | Other: fog | - | - | - | - | 1件: 6 6 |
1382 | Other: Four Square Step Test | - | - | - | - | 2件: 6 6, 13 |
1383 | Other: Functional mobility | - | - | - | - | 2件: 6 6, 13 |
1384 | Other: Functional Reach Test | - | - | - | - | 2件: 6 6, 13 |
1385 | Other: Gait and balance group training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1386 | Other: hemicellulose crystalline | - | - | - | - | 1件: 6 6 |
1387 | Other: High intensity exercise and balance training | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1388 | Other: High-intensity training in shallow and deep water | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 6 6 |
1389 | Other: Hoehn and Yahr Scale | - | - | - | - | 1件: 6 6 |
1390 | Other: Home functional balance physiotherapy | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1391 | Other: Imitation Surgical Procedure (ISP) | - | - | - | - | 1件: 6 6 |
1392 | Other: Lower Limb Strength | - | - | - | - | 1件: 6 6 |
1393 | Other: MIBG label with I123 or I124 | - | - | - | - | 1件: 6 6 |
1394 | Other: Mobile platform exercise | - | - | - | - | 1件: 6 6 |
1395 | Other: Motor Assessments before taking regular PD treatment | - | - | - | - | 1件: 6 6 |
1396 | Other: Motor Assessments on regular PD treatment | - | - | - | - | 1件: 6 6 |
1397 | Other: MP+DDCI | - | - | - | - | 1件: 6 6 |
1398 | Other: MP-Equivalent | - | - | - | - | 1件: 6 6 |
1399 | Other: MP-Low | - | - | - | - | 1件: 6 6 |
1400 | Other: MRI | - | - | - | - | 3件: 6 6, 127, 206 |
1401 | Other: Multidisciplinary intensive rehabilitation treatment | - | - | - | - | 1件: 6 6 |
1402 | Other: Music | - | - | - | - | 1件: 6 6 |
1403 | Other: Neupro 4 mg / 24 Hr. Transdermal Patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1404 | Other: Non-Motor Symptoms | - | - | - | - | 1件: 6 6 |
1405 | Other: Nordic walking (only osteoporosis group) | - | - | - | - | 1件: 6 6 |
1406 | Other: Observational cohort | - | - | - | - | 1件: 6 6 |
1407 | Other: Optional Blood-Oxygen-level Dependent functionalMRI | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 1件: 6 6 |
1408 | Other: Parkinson mPower mobile application | - | - | - | - | 1件: 6 6 |
1409 | Other: PD exercise intervention | - | - | - | - | 1件: 6 6 |
1410 | Other: PD vitamin + exercise | - | - | - | - | 1件: 6 6 |
1411 | Other: Physical Function Performance Test | - | - | - | - | 1件: 6 6 |
1412 | Other: Physical Therapy | - | - | - | - | 2件: 6 6, 70 |
1413 | Other: Pittsburgh Compound B [11C]-PIB | 1件: Pittsburgh Compound B Pittsburgh Compound B | - | - | - | 1件: 6 6 |
1414 | Other: Questionnaires | - | - | - | - | 5件: 6 6, 13, 41, 93, 96 |
1415 | Other: Recommendation with regard to nutrition | - | - | - | - | 1件: 6 6 |
1416 | Other: Rhythmic Auditory Stimulation (RAS) | - | - | - | - | 2件: 6 6, 13 |
1417 | Other: Rhythmic Balance-Movement Training (rBMT) | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1418 | Other: Rotigotine | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1419 | Other: Saline | - | - | - | - | 8件: 2 2, 6, 46, 97, 98, 256, 274, 301 |
1420 | Other: Screening to prevent falls | - | - | - | - | 1件: 6 6 |
1421 | Other: Sham group | - | - | - | - | 1件: 6 6 |
1422 | Other: Sham Surgery | - | - | - | - | 1件: 6 6 |
1423 | Other: Smartphone-based balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1424 | Other: Specific SL-therapy | - | - | - | - | 1件: 6 6 |
1425 | Other: Standardized scales: MDS-UPDRS (Part II to IV) and RDRS | - | - | - | - | 1件: 6 6 |
1426 | Other: Stool Sample | - | - | - | - | 2件: 6 6, 299 |
1427 | Other: Strength training in shallow water and dry land | 1件: Water Water | 1件: D00001
D00001
| - | - | 1件: 6 6 |
1428 | Other: Subcortical Stimulation | - | - | - | - | 1件: 6 6 |
1429 | Other: t-DCS group | - | - | - | - | 1件: 6 6 |
1430 | Other: Tampa Kinesiophobia Scale, Berg-Balance Test, International Physical Activity Questionnaire-Short Form, Falls Efficacy Scale | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1431 | Other: Telerehabilitation Based Functional Balance and Mobility Exercise | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1432 | Other: Telerehabilitation Based LSVT BIG Exercise Protocol | - | - | - | - | 1件: 6 6 |
1433 | Other: the timed 360° turn test | - | - | - | - | 1件: 6 6 |
1434 | Other: Timed Up and Go Test | - | - | - | - | 1件: 6 6 |
1435 | Other: Trunk Impairment Scale | - | - | - | - | 1件: 6 6 |
1436 | Other: tyramine | 1件: Tyramine Tyramine | - | - | - | 1件: 6 6 |
1437 | Other: Unified Parkinson's Disease Rating Scale | - | - | - | - | 1件: 6 6 |
1438 | Other: Usual care arm exercise | - | - | - | - | 1件: 6 6 |
1439 | Other: Usual drug treatment of Parkinson's disease | - | - | - | - | 1件: 6 6 |
1440 | Other: Voluntary cough test | - | - | - | - | 1件: 6 6 |
1441 | Over-encapsulated Entacapone Tablets | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1442 | Over-encapsulated Modafinil | 1件: Modafinil Modafinil | 1件: D01832
D01832
| - | - | 1件: 6 6 |
1443 | Oxaloacetate (OAA) | - | - | - | - | 1件: 6 6 |
1444 | OXB-102 | - | - | - | - | 1件: 6 6 |
1445 | OXN 10 mg / 5 mg PR | - | - | - | - | 1件: 6 6 |
1446 | OXN 20 mg / 10 mg PR | - | - | - | - | 1件: 6 6 |
1447 | OXN 5 mg/2.5 mg PR | - | - | - | - | 1件: 6 6 |
1448 | Oxybate | 1件: gamma-Hydroxybutyric acid gamma-Hydroxybutyric acid | - | - | - | 2件: 6 6, 149 |
1449 | Oxybuprocaine | 1件: Oxybuprocaine Oxybuprocaine | 2件: D01768
D01768
,
D08319
| 5件: SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 3件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬 | 1件: 6 6 |
1450 | Oxybutynin | 1件: Oxybutynin Oxybutynin | 2件: D00465
D00465
,
D00722
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 13, 53 |
1451 | Oxybutynin and darifenacin | 2件: Darifenacin Darifenacin, Oxybutynin | 4件: D00465
D00465
,
D00722
,
D01699
,
D03654
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
1452 | Oxybutynin hydrochloride | 1件: Oxybutynin Oxybutynin | 2件: D00465
D00465
,
D00722
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 13 |
1453 | OXYCODO | - | - | - | - | 1件: 6 6 |
1454 | Oxycodone | 1件: Oxycodone Oxycodone | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 13, 46, 70, 226, 231, 298 |
1455 | OXYCODONE HYDROCHLORIDE | 1件: Oxycodone Oxycodone | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 4件: 6 6, 70, 226, 298 |
1456 | Oxycodone/Naloxone Prolonged Release tablets | 2件: Naloxone Naloxone, Oxycodone | 5件: D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1457 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | 3件: Manganese citrate Manganese citrate, Naloxone, Oxycodone | 5件: D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1458 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | 3件: Manganese citrate Manganese citrate, Naloxone, Oxycodone | 5件: D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1459 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | 3件: Manganese citrate Manganese citrate, Naloxone, Oxycodone | 5件: D01340
D01340
,
D03783
,
D05312
,
D05462
,
D08249
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1460 | Oxycontin LP 10mg | 1件: Oxycodone Oxycodone | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1461 | Oxycontin LP 20mg | 1件: Oxycodone Oxycodone | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1462 | Oxycontin LP 5mg | 1件: Oxycodone Oxycodone | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1463 | Oxygen | 1件: Oxygen Oxygen | 1件: D00003
D00003
| - | - | 20件: 6 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330 |
1464 | Oxytocin | 1件: Oxytocin Oxytocin | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 6件: 6 6, 72, 127, 193, 206, 226 |
1465 | OXYTOCIN SYNTHETIC | 1件: Oxytocin Oxytocin | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1466 | P2B001 | - | - | - | - | 1件: 6 6 |
1467 | P2B001 once daily (pramipexole 0.3 mg / rasagiline 0.75 mg), | 2件: Pramipexole Pramipexole, Rasagiline | 5件: D00559
D00559
,
D02562
,
D05575
,
D08469
,
D10829
| 4件: DRD2 DRD2, DRD3, DRD4, MAOB 💬 | 18件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1468 | P2B001 once daily (pramipexole 0.6 mg / rasagiline 0.75 mg), | 2件: Pramipexole Pramipexole, Rasagiline | 5件: D00559
D00559
,
D02562
,
D05575
,
D08469
,
D10829
| 4件: DRD2 DRD2, DRD3, DRD4, MAOB 💬 | 18件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1469 | PARACETAMOL | 1件: Acetaminophen Acetaminophen | 1件: D00217
D00217
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 6件: 3 3, 6, 13, 35, 46, 49 |
1470 | Parapres | - | - | - | - | 1件: 6 6 |
1471 | PARCOPA | - | - | - | - | 1件: 6 6 |
1472 | Pardaprunox | - | - | - | - | 1件: 6 6 |
1473 | Pardoprunox | 1件: Pardoprunox Pardoprunox | 1件: D09397
D09397
| 3件: DRD2 DRD2, DRD3, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
1474 | Pardoprunox hydrochloride | 1件: Pardoprunox Pardoprunox | 1件: D09397
D09397
| 3件: DRD2 DRD2, DRD3, HTR1A 💬 | 10件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
1475 | Paroxetine | 1件: Paroxetine Paroxetine | 4件: D02260
D02260
,
D02362
,
D05374
,
D05375
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 4件: 6 6, 13, 46, 85 |
1476 | Part 1, JM-010 component Group A | - | - | - | - | 1件: 6 6 |
1477 | Part 1, JM-010 component Group B | - | - | - | - | 1件: 6 6 |
1478 | Part 1, JM-010 component Group C | - | - | - | - | 1件: 6 6 |
1479 | Part 2, JM-010 combination Group A | - | - | - | - | 1件: 6 6 |
1480 | Part 2, JM-010 combination Group B | - | - | - | - | 1件: 6 6 |
1481 | Part 2, JM-010 component Group C | - | - | - | - | 1件: 6 6 |
1482 | PAT | - | - | - | - | 3件: 6 6, 13, 160 |
1483 | PBF-509 | - | - | - | - | 1件: 6 6 |
1484 | PD patients H&Y=1.5-2 Medications OFF | - | - | - | - | 1件: 6 6 |
1485 | PD patients H&Y=1.5-2 Medications ON | - | - | - | - | 1件: 6 6 |
1486 | PD patients H&Y=3 Medications OFF | - | - | - | - | 1件: 6 6 |
1487 | PD patients H&Y=3 Medications ON | - | - | - | - | 1件: 6 6 |
1488 | PD vitamin supplementation | - | - | - | - | 1件: 6 6 |
1489 | PEG | - | - | - | - | 12件: 6 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 240, 299 |
1490 | PEG tube | - | - | - | - | 1件: 6 6 |
1491 | Perampanel | 1件: Perampanel Perampanel | 1件: D08964
D08964
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 3件: 2 2, 6, 144 |
1492 | Percutaneous endoscopic gastrostomy tube | - | - | - | - | 1件: 6 6 |
1493 | Percutaneous endoscopic gastrostomy tube (PEG tube) | - | - | - | - | 1件: 6 6 |
1494 | Percutaneous Endoscopic Gastrostomy with Jejunal Extension (PEG-J) | - | - | - | - | 1件: 6 6 |
1495 | PERGOLIDE | 1件: Pergolide Pergolide | 2件: D00502
D00502
,
D08339
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1496 | PET | - | - | - | - | 1件: 6 6 |
1497 | PET/CT | - | - | - | - | 1件: 6 6 |
1498 | PF-06412562 | - | - | - | - | 1件: 6 6 |
1499 | PF-06649751 | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1500 | PF-06649751 - 15mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1501 | PF-06649751 - 1mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1502 | PF-06649751 - 5mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1503 | PF-06649751 high dose (15 mg QD) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1504 | PF-06649751 low dose (1 mg QD) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1505 | PF-06649751 middle dose 1 (3 mg QD) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1506 | PF-06649751 middle dose 2 (7 mg QD) | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1507 | PF-06669571 | - | - | - | - | 1件: 6 6 |
1508 | PG203 | - | - | - | - | 1件: 6 6 |
1509 | Ph. Eur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | 1件: Propanoic acid Propanoic acid | 1件: D02310
D02310
| - | - | 1件: 6 6 |
1510 | Ph. Eur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylprop acid | - | - | - | - | 1件: 6 6 |
1511 | Phenlarmide Tablets | - | - | - | - | 1件: 6 6 |
1512 | PHENYLBUTYRATE | 1件: Phenylbutyric acid Phenylbutyric acid | - | - | - | 12件: 2 2, 3, 6, 8, 15, 93, 94, 244, 251, 297, 299, 338 |
1513 | PhEur.: (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoic acid | 1件: Propanoic acid Propanoic acid | 1件: D02310
D02310
| - | - | 1件: 6 6 |
1514 | PhEur.: (2S)-3-(3,4-dihydroxyphenyl)-2hydrazino-2methylpropanoic acid | - | - | - | - | 1件: 6 6 |
1515 | Phosphate | 1件: Phosphate ion Phosphate ion | - | - | - | 33件: 2 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299 |
1516 | Physical exam and UPDRS part III assessment | - | - | - | - | 1件: 6 6 |
1517 | Piclozotan | 1件: Piclozotan Piclozotan | - | - | - | 1件: 6 6 |
1518 | Pilocarpine | 1件: Pilocarpine Pilocarpine | 3件: D00525
D00525
,
D02200
,
D05478
| 2件: CHRM2 CHRM2, CHRM3 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 3件: 6 6, 53, 299 |
1519 | Pimavanserin | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
1520 | Pimavanserin (ACP-103) | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
1521 | Pimavanserin tartrate | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
1522 | Pimavanserin tartrate (ACP-103) | 1件: Pimavanserin Pimavanserin | - | - | - | 1件: 6 6 |
1523 | Pioglitazone | 1件: Pioglitazone Pioglitazone | 2件: D00945
D00945
,
D08378
| 1件: PPARG PPARG 💬 | 11件: AMPK signaling pathway AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | 17件: 2 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 |
1524 | Pirepemat | - | - | - | - | 1件: 6 6 |
1525 | Piribedil | 1件: Piribedil Piribedil | 1件: D07305
D07305
| 2件: DRD2 DRD2, DRD3 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1526 | Piribedil (Clarium) | 1件: Piribedil Piribedil | 1件: D07305
D07305
| 2件: DRD2 DRD2, DRD3 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1527 | Pitolisant | 1件: Pitolisant Pitolisant | 1件: D10749
D10749
| 1件: HRH3 HRH3 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 113, 193 |
1528 | Pittsburgh Compound B | 1件: Pittsburgh Compound B Pittsburgh Compound B | - | - | - | 2件: 6 6, 127 |
1529 | PK-Merz | - | - | - | - | 1件: 6 6 |
1530 | PK-Merz® 200mg/500ml inj(Amantadine) , Normal saline 500ml inj | 1件: Amantadine Amantadine | 2件: D00777
D00777
,
D07441
| 5件: GRIN1 GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 | 1件: 6 6 |
1531 | Placebo | - | - | - | - | 27件: 3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
1532 | Plantago ovata husk | - | - | - | - | 1件: 6 6 |
1533 | Polyethylene glycol | 1件: Polyethylene glycol Polyethylene glycol | 1件: D03370
D03370
| - | - | 7件: 6 6, 78, 96, 97, 235, 276, 299 |
1534 | Posiphen | 1件: Posiphen Posiphen | - | - | - | 1件: 6 6 |
1535 | Positron Emission Tomography using [11 Carbon]-3-amino-4-(2-dimethylaminomethylphenylsulfanyl)-benzonitrile ([11C]-DASB) and [18 Fluorine]-altanserin ([18F]-altanserin) | 1件: Activated charcoal Activated charcoal | - | - | - | 1件: 6 6 |
1536 | Positron Emission Tomography using [18 Fluorine]-altanserin ([18F]-altanserin) | - | - | - | - | 1件: 6 6 |
1537 | PR Oxycodone | 1件: Oxycodone Oxycodone | 3件: D03783
D03783
,
D05312
,
D05462
| 3件: OPRD1 OPRD1, OPRK1, OPRM1 💬 | 5件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1538 | PR001 | - | - | - | - | 2件: 6 6, 19 |
1539 | Pramipexol | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1540 | Pramipexol Extended Release | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1541 | Pramipexol Immediate Release | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1542 | Pramipexole | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 20 |
1543 | Pramipexole 0.125 mg tablets | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1544 | Pramipexole 0.5 mg tablets | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1545 | PRAMIPEXOLE DIHYDROCHLORIDE | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1546 | Pramipexole dihydrochloride extended-release tablets | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1547 | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1548 | Pramipexole dihydrochloride monohydrate extended release | 2件: Manganese citrate Manganese citrate, Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1549 | Pramipexole ER | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1550 | Pramipexole Extended Release | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1551 | Pramipexole extended release tablet | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1552 | Pramipexole hydrochloride sustained-release tablet (Siforl®) Specification: 0.26mg/ tablet (in pramipexole) | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1553 | Pramipexole Immediate Release | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1554 | Pramipexole immediate release tablet | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1555 | Pramipexole IR | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1556 | Pramipexole or ropinirole | 2件: Pramipexole Pramipexole, Ropinirole | 4件: D00559
D00559
,
D00784
,
D05575
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1557 | Pramipexole SR | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1558 | Prasinezumab | 1件: Prasinezumab Prasinezumab | 1件: D11420
D11420
| 1件: SNCA SNCA 💬 | 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1559 | Praxol hydrochloride sustained release tablet Specification: 0.375mg/ tablet (in pramipexole hydrochloride) | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1560 | Prednisone | 1件: Prednisone Prednisone | 1件: D00473
D00473
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 48件: 2 2, 6, 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 95, 96, 97, 113, 127, 162, 164, 205, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
1561 | Preladenant | 1件: Preladenant Preladenant | 1件: D09717
D09717
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1562 | Preladenant 10 mg tablet | 1件: Preladenant Preladenant | 1件: D09717
D09717
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1563 | Preladenant 2 mg tablet | 1件: Preladenant Preladenant | 1件: D09717
D09717
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1564 | Preladenant 5 mg tablet | 1件: Preladenant Preladenant | 1件: D09717
D09717
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1565 | Premarin ® | - | - | - | - | 1件: 6 6 |
1566 | Pridia (Donepezil Hydrochloride) 5mg | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1567 | Pridia 10mg | - | - | - | - | 1件: 6 6 |
1568 | Pridia 5mg | - | - | - | - | 1件: 6 6 |
1569 | Pridopidine | 1件: Pridopidine Pridopidine | 1件: D09953
D09953
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 2 2, 6, 8 |
1570 | PRIM-DJ2727 | - | - | - | - | 2件: 6 6, 97 |
1571 | Primary Cervical Dystonia (Trihexyphenidyl) | 1件: Trihexyphenidyl Trihexyphenidyl | 2件: D00787
D00787
,
D08638
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
1572 | Primavanserin tartrate | - | - | - | - | 1件: 6 6 |
1573 | Prior Donepezil 5mg | 1件: Donepezil Donepezil | 2件: D00670
D00670
,
D07869
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1574 | Prior Donzepezil 10mg | - | - | - | - | 1件: 6 6 |
1575 | Probiotic | - | - | - | - | 7件: 2 2, 6, 93, 96, 97, 193, 266 |
1576 | Probiotic Capsule | - | - | - | - | 1件: 6 6 |
1577 | Probiotics | - | - | - | - | 5件: 6 6, 94, 96, 97, 291 |
1578 | Probiotics with prebiotic | - | - | - | - | 1件: 6 6 |
1579 | Prolonged release tablet | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
1580 | Prolopa® | - | - | - | - | 1件: 6 6 |
1581 | Propanoic acid | 2件: Naproxen Naproxen, Propanoic acid | 2件: D00118
D00118
,
D02310
| 2件: PTGS1 PTGS1, PTGS2 💬 | 23件: Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | 2件: 6 6, 271 |
1582 | PROPOFOL | 1件: Propofol Propofol | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 9件: 6 6, 21, 22, 34, 46, 70, 84, 98, 296 |
1583 | Propofol-Lipuro | 1件: Propofol Propofol | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
1584 | Propranolol | 1件: Propranolol Propranolol | 2件: D00483
D00483
,
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 158, 167, 215, 227, 278 |
1585 | Propranolol HCl CF 40 mg tablet | 1件: Propranolol Propranolol | 2件: D00483
D00483
,
D08443
| 3件: ADRB1 ADRB1, ADRB2, ADRB3 💬 | 12件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1586 | ProSavin | - | - | - | - | 1件: 6 6 |
1587 | PROSCAR*30CPR RIV 5MG | 1件: Finasteride Finasteride | 1件: D00321
D00321
| 1件: SRD5A2 SRD5A2 💬 | 3件: Metabolic pathways Metabolic pathways, Prostate cancer, Steroid hormone biosynthesis 💬 | 1件: 6 6 |
1588 | PRX002 | - | - | - | - | 1件: 6 6 |
1589 | PRX002, ELT2, anti-alpha-synuclein monoclonal antibody | - | - | - | - | 1件: 6 6 |
1590 | PS | - | - | - | - | 4件: 6 6, 46, 90, 97 |
1591 | PS128 | - | - | - | - | 1件: 6 6 |
1592 | Psilocybin | 1件: Psilocybin Psilocybin | - | - | - | 1件: 6 6 |
1593 | Psilocybin therapy | 1件: Psilocybin Psilocybin | - | - | - | 1件: 6 6 |
1594 | Psilocybine | 1件: Psilocybin Psilocybin | - | - | - | 1件: 6 6 |
1595 | Psyllium | 1件: Plantago seed Plantago seed | 1件: D05525
D05525
| - | - | 3件: 6 6, 28, 97 |
1596 | PT320 2.0 mg | - | - | - | - | 1件: 6 6 |
1597 | PT320 2.5 mg | - | - | - | - | 1件: 6 6 |
1598 | PXT002331 | - | - | - | - | 1件: 6 6 |
1599 | PXT002331 - 20mg | - | - | - | - | 1件: 6 6 |
1600 | PXT002331 - dose 1 | - | - | - | - | 1件: 6 6 |
1601 | PXT002331 - dose 2 | - | - | - | - | 1件: 6 6 |
1602 | PYM50028 | - | - | - | - | 1件: 6 6 |
1603 | Pyridostigmine | 1件: Pyridostigmine Pyridostigmine | 1件: D00487
D00487
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 4件: 3 3, 6, 11, 256 |
1604 | Pyridostigmine Bromide | 1件: Pyridostigmine Pyridostigmine | 1件: D00487
D00487
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 3 3, 6, 256 |
1605 | Quetiapine | 1件: Quetiapine Quetiapine | 2件: D00458
D00458
,
D08456
| 2件: DRD2 DRD2, HTR2A 💬 | 11件: Alcoholism Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 💬 | 2件: 6 6, 13 |
1606 | R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane hydrochloride | 1件: Benzofuran Benzofuran | - | - | - | 1件: 6 6 |
1607 | R-metHuGDNF | 1件: Liatermin Liatermin | 1件: D04727
D04727
| - | - | 1件: 6 6 |
1608 | RAAV-GAD | - | - | - | - | 1件: 6 6 |
1609 | Raclopride | 1件: Raclopride Raclopride | - | - | - | 4件: 5 5, 6, 7, 17 |
1610 | Racol | - | - | - | - | 3件: 6 6, 96, 291 |
1611 | Radiation: [18-Fluorine] Flubatine PET Scan | - | - | - | - | 1件: 6 6 |
1612 | Radiation: Fluoroscopy | - | - | - | - | 1件: 6 6 |
1613 | Radiation: H215O PET | - | - | - | - | 2件: 6 6, 17 |
1614 | Radiation: PET with the tracer 11C-PE2I | - | - | - | - | 1件: 6 6 |
1615 | Radiation: PET with the tracer 18F-DPA-714 | - | - | - | - | 1件: 6 6 |
1616 | Radiation: PET/MR with [11C]PBR28 | - | - | - | - | 1件: 6 6 |
1617 | Radiation: Radiosurgical thalamotomy | - | - | - | - | 1件: 6 6 |
1618 | Radiation: Videofluoroscopic swallow evaluation | - | - | - | - | 1件: 6 6 |
1619 | Radotinib | 1件: Radotinib Radotinib | - | - | - | 1件: 6 6 |
1620 | Radotinib HCl 50 mg | 1件: Radotinib Radotinib | - | - | - | 1件: 6 6 |
1621 | Ramelteon | 1件: Ramelteon Ramelteon | 1件: D02689
D02689
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 8, 46 |
1622 | RAS | - | - | - | - | 4件: 6 6, 13, 58, 66 |
1623 | Rasagilin | - | - | - | - | 2件: 5 5, 6 |
1624 | Rasagilina | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1625 | RASAGILINA MESILATO | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1626 | Rasagilina mesilato (12 weeks) | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1627 | Rasagiline | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 4件: 2 2, 5, 6, 17 |
1628 | Rasagiline 1 mg capsule | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1629 | Rasagiline 1mg tablet | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1630 | Rasagiline 2 mg tablet | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1631 | RASAGILINE MESILATE | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 3件: 2 2, 5, 6 |
1632 | RASAGILINE MESYLATE | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1633 | Rasagiline mesylate 1.0 mg | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1634 | Rasagiline mesylate plus Mirapex | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1635 | Rasagiline mesylate with Levodopa | 2件: Levodopa Levodopa, Rasagiline | 4件: D00059
D00059
,
D02562
,
D08469
,
D10829
| 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 | 20件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1636 | Rasagiline mesylate with Requip | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1637 | Rasagiline tablets | 1件: Rasagiline Rasagiline | 3件: D02562
D02562
,
D08469
,
D10829
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1638 | Recombinant human Cerebral Dopamine Neurotrophic Factor | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1639 | Recombinant-methionyl human glial cell line-derived neurotrophic factor | - | - | - | - | 1件: 6 6 |
1640 | Reduced Glutathione | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 2件: 6 6, 299 |
1641 | Reduced Glutathione 100mg | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 6 6 |
1642 | Reduced Glutathione 200mg | 1件: Glutathione Glutathione | 2件: D00014
D00014
,
D00031
| - | - | 1件: 6 6 |
1643 | Regular Novolin R | - | - | - | - | 1件: 6 6 |
1644 | Release | 1件: Manganese citrate Manganese citrate | - | - | - | 12件: 6 6, 8, 13, 46, 65, 78, 81, 96, 97, 206, 226, 299 |
1645 | Remifentanil | 1件: Remifentanil Remifentanil | 2件: D01177
D01177
,
D08473
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 2件: 6 6, 70 |
1646 | Remifentanyl | 1件: Remifentanil Remifentanil | 2件: D01177
D01177
,
D08473
| 1件: OPRM1 OPRM1 💬 | 3件: Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1647 | Reminyl | - | - | - | - | 1件: 6 6 |
1648 | Reminyl Retard | - | - | - | - | 1件: 6 6 |
1649 | Renishaw Drug Delivery System | - | - | - | - | 1件: 6 6 |
1650 | Repaglinide | 1件: Repaglinide Repaglinide | 1件: D00594
D00594
| 2件: ABCC8 ABCC8, KCNJ11 💬 | 4件: ABC transporters ABC transporters, GnRH secretion, Insulin secretion, Type II diabetes mellitus 💬 | 3件: 6 6, 21, 299 |
1651 | REQUIP | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 309 |
1652 | REQUIP 21 CPR 0,25 MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1653 | REQUIP 21 CPR 0,5 MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1654 | REQUIP 21 CPR 1 MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1655 | REQUIP 21 CPR 2 MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1656 | ReQuip CR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 2 2, 6 |
1657 | Requip Modutab, 2mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1658 | Requip Modutab, 4mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1659 | Requip Modutab, 8mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1660 | ReQuip PR | - | - | - | - | 1件: 6 6 |
1661 | Requip prolonged release | 2件: Manganese citrate Manganese citrate, Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1662 | Requip XL prolonged-release | 2件: Manganese citrate Manganese citrate, Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1663 | REQUIP*21CPR 0,25MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1664 | REQUIP*21CPR 0,5MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1665 | REQUIP*21CPR 1MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1666 | REQUIP*21CPR 5MG | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1667 | REQUIP*28CPR 8MG R.P. | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1668 | REQUIP-LP | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1669 | Requip-Modutab | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1670 | REQUIP-MODUTAB , 2mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1671 | REQUIP-MODUTAB , 4mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1672 | REQUIP-MODUTAB , 8mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1673 | REQUIP-MODUTAB, 2mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1674 | REQUIP-MODUTAB, 4mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1675 | REQUIP-MODUTAB, 8mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1676 | Resistant maltodextrin | 1件: Maltodextrin Maltodextrin | 1件: D02329
D02329
| - | - | 1件: 6 6 |
1677 | Resistant starch | - | - | - | - | 1件: 6 6 |
1678 | Resistive respiratory loads | - | - | - | - | 1件: 6 6 |
1679 | Restex Tabletten | - | - | - | - | 1件: 6 6 |
1680 | Rifampicin | 1件: Rifampicin Rifampicin | 1件: D00211
D00211
| - | - | 6件: 6 6, 17, 46, 93, 299, 338 |
1681 | Rifampin | 1件: Rifampicin Rifampicin | 1件: D00211
D00211
| - | - | 5件: 6 6, 13, 84, 86, 299 |
1682 | Rifampin 300mg BID + istradefylline 40mg Day 8 only | 2件: Istradefylline Istradefylline, Rifampicin | 2件: D00211
D00211
,
D04641
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1683 | Rifaximin | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 7件: 6 6, 65, 93, 96, 97, 99, 296 |
1684 | Rifaximin 550 MG | 1件: Rifaximin Rifaximin | 1件: D02554
D02554
| - | - | 1件: 6 6 |
1685 | Ritalin | 1件: Methylphenidate Methylphenidate | 2件: D01296
D01296
,
D04999
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 2件: 6 6, 13 |
1686 | Rituximab | 1件: Rituximab Rituximab | 1件: D02994
D02994
| 1件: MS4A1 MS4A1 💬 | 1件: Hematopoietic cell lineage Hematopoietic cell lineage 💬 | 49件: 6 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 |
1687 | RIV-TDS 13.3 mg/24 h | - | - | - | - | 1件: 6 6 |
1688 | Rivastigmin Luye Transdermal Patches - 4.6mg/24h | - | - | - | - | 1件: 6 6 |
1689 | RIVASTIGMINE | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 3件: 5 5, 6, 13 |
1690 | Rivastigmine capsule | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1691 | Rivastigmine CF | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1692 | Rivastigmine Luye Transdermal Patch- 9.5mg/24h | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1693 | Rivastigmine Patch 9.5 cm2 | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1694 | Rivastigmine transdermal patch | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 2件: 6 6, 13 |
1695 | Rivastigmine Transdermal System | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1696 | Rivastigmine transdermal system 13.3 mg/24 h | 1件: Rivastigmine Rivastigmine | 2件: D02558
D02558
,
D03822
| 1件: ACHE ACHE 💬 | 2件: Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism 💬 | 1件: 6 6 |
1697 | RM-131 | - | - | - | - | 1件: 6 6 |
1698 | RO | - | - | - | - | 1件: 6 6 |
1699 | RO7046015 | - | - | - | - | 1件: 6 6 |
1700 | RO7046015/PRASINEZUMAB | 1件: Prasinezumab Prasinezumab | 1件: D11420
D11420
| 1件: SNCA SNCA 💬 | 3件: Alzheimer disease Alzheimer disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1701 | ROP | - | - | - | - | 1件: 6 6 |
1702 | ROP+L-Dopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1703 | ROPINIROLE | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 74, 309 |
1704 | Ropinirole (as hydrochloride) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1705 | Ropinirole controlled-release (REQUIP CR) for RLS | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1706 | Ropinirole CR 2mg tablet | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1707 | Ropinirole CR 8mg tablet | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1708 | Ropinirole Hydrochloride | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 309 |
1709 | Ropinirole hydrochloride extended-release tablet | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1710 | Ropinirole hydrochloride extended-release tablet placebo | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1711 | Ropinirole hydrochloride prolonged release | 2件: Manganese citrate Manganese citrate, Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1712 | Ropinirole immediate release | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1713 | Ropinirole Implant | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1714 | Ropinirole IR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1715 | Ropinirole IR Tablets | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1716 | Ropinirole monotherapy | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1717 | Ropinirole oral product | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1718 | Ropinirole PR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1719 | Ropinirole PR, 2mg | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1720 | Ropinirole PR/XR | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1721 | Ropinirole PR/XR Tablets | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1722 | Ropinirole Prolonged release | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1723 | Ropinirole prolonged release/extended release(PR/XR) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1724 | Ropinirole XL | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1725 | Ropinirole XL (formerly CR) | 1件: Ropinirole Ropinirole | 2件: D00784
D00784
,
D08489
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1726 | Ropinirole/L-dopa | 2件: Levodopa Levodopa, Ropinirole | 3件: D00059
D00059
,
D00784
,
D08489
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1727 | Rosuvastatin | 1件: Rosuvastatin Rosuvastatin | 2件: D01915
D01915
,
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
1728 | ROT-TDS 8 mg/24 h | - | - | - | - | 1件: 6 6 |
1729 | Rotigotin | - | - | - | - | 1件: 6 6 |
1730 | ROTIGOTINA | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1731 | ROTIGOTINE | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 2件: 6 6, 127 |
1732 | Rotigotine (Reference product PR 2.1.1) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1733 | Rotigotine (Test product PR 2.3.1) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1734 | Rotigotine hydrochloride | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1735 | Rotigotine Nasal Spray | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1736 | Rotigotine transdermal patch | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1737 | Rotigotine transdermal patch 2mg/24h(10cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1738 | Rotigotine transdermal patch 4mg/24h (20cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1739 | Rotigotine transdermal patch 6mg/24h (30cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1740 | Rotigotine transdermal patch 8mg/24h (40cm2) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1741 | Rotigotine TTS (Test) | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1742 | Rotigotine, extended-release microspheres | 1件: Rotigotine Rotigotine | 1件: D05768
D05768
| 1件: DRD2 DRD2 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1743 | ROZEREM | 1件: Ramelteon Ramelteon | 1件: D02689
D02689
| 2件: MTNR1A MTNR1A, MTNR1B 💬 | 2件: Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1744 | RQ-00000010 | - | - | - | - | 1件: 6 6 |
1745 | RVG 08740 | - | - | - | - | 1件: 6 6 |
1746 | RVG 55618 | - | - | - | - | 1件: 6 6 |
1747 | RVT-101 35 mg | - | - | - | - | 1件: 6 6 |
1748 | RYAH-Medtech Inhaler | - | - | - | - | 5件: 2 2, 6, 13, 96, 97 |
1749 | Rytary 145 mg | - | - | - | - | 1件: 6 6 |
1750 | Rytary 195 mg | - | - | - | - | 1件: 6 6 |
1751 | S 90049 | - | - | - | - | 1件: 6 6 |
1752 | S 90049 - F36 | - | - | - | - | 1件: 6 6 |
1753 | S 90049 - F38 | - | - | - | - | 1件: 6 6 |
1754 | S.c. apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1755 | S90049 | - | - | - | - | 1件: 6 6 |
1756 | SA | - | - | - | - | 5件: 6 6, 30, 60, 118, 298 |
1757 | Safety observation | - | - | - | - | 1件: 6 6 |
1758 | Safinamida | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1759 | SAFINAMIDE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1760 | Safinamide (as add-on therapy) | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1761 | Safinamide + Levodopa | 2件: Levodopa Levodopa, Safinamide | 2件: D00059
D00059
,
D10158
| 6件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5, MAOB 💬 | 20件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Gap junction, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1762 | SAFINAMIDE METANSOLFONATO | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1763 | Safinamide metansolfonato (12 weeks) | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1764 | SAFINAMIDE METHANESULFONATE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
1765 | Safinamide Methanesulfonate 100mg | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1766 | Safinamide Methanesulfonate 150mg | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1767 | Safinamide methansulfonate | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1768 | Safinamide, MAO-B inhibitor | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1769 | Safinimide 50-100 mg/day | - | - | - | - | 1件: 6 6 |
1770 | Sage | 1件: Sage Sage | - | - | - | 1件: 6 6 |
1771 | Sage leaf | 1件: Sage Sage | - | - | - | 1件: 6 6 |
1772 | SAGE-217 | - | - | - | - | 1件: 6 6 |
1773 | SAGE-718 | - | - | - | - | 2件: 6 6, 8 |
1774 | Saline | - | - | - | - | 10件: 6 6, 13, 17, 53, 67, 78, 86, 97, 168, 299 |
1775 | Saline Intranasal Delivery | - | - | - | - | 1件: 6 6 |
1776 | SAM | - | - | - | - | 1件: 6 6 |
1777 | SAM-e | 1件: Ademetionine Ademetionine | 1件: D07128
D07128
| - | - | 1件: 6 6 |
1778 | SAR402671, GZ402671 or GZ/SAR402671 | - | - | - | - | 3件: 6 6, 19, 67 |
1779 | Saracatinib | 1件: Saracatinib Saracatinib | 1件: D09664
D09664
| 2件: ABL1 ABL1, SRC 💬 | 49件: Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, C-type lectin receptor signaling pathway, Cell cycle, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, GnRH signaling pathway, Hepatitis B, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MicroRNAs in cancer, Mitophagy - animal, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Prolactin signaling pathway, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | 3件: 6 6, 89, 272 |
1780 | Sarcosine | 1件: Sarcosine Sarcosine | - | - | - | 1件: 6 6 |
1781 | Sarcosine Capsule | 1件: Sarcosine Sarcosine | - | - | - | 1件: 6 6 |
1782 | Sargramostim | 1件: Sargramostim Sargramostim | 1件: D05803
D05803
| 1件: CSF2RA CSF2RA 💬 | 4件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬 | 7件: 6 6, 28, 60, 62, 96, 229, 285 |
1783 | SARIZOTAN | 1件: Sarizotan Sarizotan | - | - | - | 2件: 6 6, 156 |
1784 | Sarizotan HC1 | 1件: Sarizotan Sarizotan | - | - | - | 1件: 6 6 |
1785 | Sarizotan HCl | 1件: Sarizotan Sarizotan | - | - | - | 1件: 6 6 |
1786 | Sarizotan Hydrochloride | 1件: Sarizotan Sarizotan | - | - | - | 2件: 6 6, 156 |
1787 | SCH 420814 | - | - | - | - | 1件: 6 6 |
1788 | SCH 420814 10 mg | - | - | - | - | 1件: 6 6 |
1789 | SCH 420814 100 mg | - | - | - | - | 1件: 6 6 |
1790 | SCH 900800 | - | - | - | - | 1件: 6 6 |
1791 | SCH420814 | - | - | - | - | 1件: 6 6 |
1792 | SCP | - | - | - | - | 1件: 6 6 |
1793 | Sedation with IV propofol | 1件: Propofol Propofol | 1件: D00549
D00549
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
1794 | SELEGILINE | 1件: Selegiline Selegiline | 2件: D00785
D00785
,
D03731
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1795 | Selegiline HCl 5 PCH | 1件: Selegiline Selegiline | 2件: D00785
D00785
,
D03731
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1796 | Semaglutide | 1件: Semaglutide Semaglutide | 1件: D10025
D10025
| 1件: GLP1R GLP1R 💬 | 3件: Insulin secretion Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | 1件: 6 6 |
1797 | Semi continuous intra-oral administration of LD/CD | - | - | - | - | 1件: 6 6 |
1798 | Senfrol monotherapy | - | - | - | - | 1件: 6 6 |
1799 | SEP-363856 | 1件: SEP-363856 SEP-363856 | - | - | - | 1件: 6 6 |
1800 | SER-214 | - | - | - | - | 1件: 6 6 |
1801 | Serine | 1件: Serine Serine | 1件: D00016
D00016
| - | - | 4件: 2 2, 6, 86, 96 |
1802 | Seroquel | - | - | - | - | 1件: 6 6 |
1803 | Sertraline | 1件: Sertraline Sertraline | 2件: D00825
D00825
,
D02360
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 2件: 6 6, 206 |
1804 | Sevoflurane | 1件: Sevoflurane Sevoflurane | 1件: D00547
D00547
| - | - | 7件: 6 6, 21, 22, 34, 98, 225, 296 |
1805 | Sham compression | - | - | - | - | 2件: 6 6, 17 |
1806 | Sham Surgery | - | - | - | - | 1件: 6 6 |
1807 | Sham tDCS | - | - | - | - | 1件: 6 6 |
1808 | Sham tPCS | - | - | - | - | 1件: 6 6 |
1809 | Sifol | - | - | - | - | 1件: 6 6 |
1810 | SIFROL | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1811 | Sifrol 0,088 | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1812 | Sifrol 0,18 | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1813 | Sifrol 0,35 | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1814 | Sifrol 0,7 | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1815 | Sifrol, 0,35 mg Tablette | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1816 | Sifrol, 0,70 mg Tablette | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1817 | Sifrol, Mirapexin | 1件: Pramipexole Pramipexole | 2件: D00559
D00559
,
D05575
| 3件: DRD2 DRD2, DRD3, DRD4 💬 | 8件: Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1818 | Sifrol® | - | - | - | - | 1件: 6 6 |
1819 | Sildenafil | 1件: Sildenafil Sildenafil | 2件: D02229
D02229
,
D08514
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 17件: 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 |
1820 | Silicon | 1件: Silicon Silicon | - | - | - | 1件: 6 6 |
1821 | Silodosin | 1件: Silodosin Silodosin | 1件: D01965
D01965
| 1件: ADRA1A ADRA1A 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1822 | Simvastatin | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 21件: 6 6, 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 |
1823 | Simvastatine | 1件: Simvastatin Simvastatin | 1件: D00434
D00434
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 6 6, 13, 288 |
1824 | SINEMET | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1825 | Sinemet (carbidopa/levodopa) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1826 | Sinemet (comparator) | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1827 | Sinemet (levodopa/carbidopa) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1828 | SINEMET - 100 MG + 25 MG COMPRESSE 50 COMPRESSE DIVISIBILI | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1829 | SINEMET 10-100 | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1830 | SINEMET 100 mg + 25 mg compresse | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1831 | SINEMET 100 mg + 25 mg tablets | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1832 | SINEMET 125 | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1833 | Sinemet 125 mg | - | - | - | - | 1件: 6 6 |
1834 | Sinemet 200mg/50mg | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1835 | SINEMET 25-100 | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1836 | Sinemet 25-100 Oral Tablet | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1837 | SINEMET 25/100 | - | - | - | - | 1件: 6 6 |
1838 | SINEMET CR | - | - | - | - | 1件: 6 6 |
1839 | Sinemet CR 25Mg-100Mg Extended-Release Tablet | 2件: Carbidopa Carbidopa, Manganese citrate | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1840 | Sinemet IR | - | - | - | - | 1件: 6 6 |
1841 | SINEMET Plus | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1842 | Sinemet plus (levodopa/carbidopa) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1843 | SINEMET*50CPR 100MG+25MG | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1844 | Sinemet-Plus Tablets | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1845 | Sinemet® | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1846 | Sinemet® 100/25 | - | - | - | - | 1件: 6 6 |
1847 | Sinemet® 100/25 mg | - | - | - | - | 1件: 6 6 |
1848 | Sinemet® controlled release (Carbidopa/levodopa) | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1849 | Sinemet® CR | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1850 | Sinemet® CR 100/25 | - | - | - | - | 1件: 6 6 |
1851 | SINEMET® Plus 25 mg/100 mg Tablets | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1852 | SINEMET®-Plus Tablets | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1853 | Sinemet®25-100 | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1854 | SIRIO*30CPR EFF 25MG+100MG | - | - | - | - | 1件: 6 6 |
1855 | Sirolimus | 1件: Sirolimus Sirolimus | 1件: D00753
D00753
| 1件: MTOR MTOR 💬 | 51件: AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | 36件: 6 6, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 89, 98, 127, 137, 157, 158, 192, 222, 277, 278, 279, 280, 281, 283, 285, 331 |
1856 | Sitagliptin | 1件: Sitagliptin Sitagliptin | 1件: D08516
D08516
| 1件: DPP4 DPP4 💬 | 1件: Protein digestion and absorption Protein digestion and absorption 💬 | 4件: 6 6, 75, 233, 299 |
1857 | SK&F101468 | - | - | - | - | 1件: 6 6 |
1858 | SKF-101468A | - | - | - | - | 1件: 6 6 |
1859 | SLV308 | - | - | - | - | 1件: 6 6 |
1860 | SLV308 (mono) hydro | - | - | - | - | 1件: 6 6 |
1861 | SLV308 (mono) hydrochlo | - | - | - | - | 1件: 6 6 |
1862 | SLV308 (mono) hydrochlori | - | - | - | - | 1件: 6 6 |
1863 | SLV308 (mono) hydrochloride | - | - | - | - | 1件: 6 6 |
1864 | SLV308 (mono)hydrochloride | - | - | - | - | 1件: 6 6 |
1865 | SLV308 hydrochloride | - | - | - | - | 1件: 6 6 |
1866 | SLV308(mono)hydrochloride | - | - | - | - | 1件: 6 6 |
1867 | SMILAGENIN | 1件: Smilagenin Smilagenin | - | - | - | 1件: 6 6 |
1868 | SND 919 CL2 Y | - | - | - | - | 1件: 6 6 |
1869 | SND 919 CL2Y | - | - | - | - | 1件: 6 6 |
1870 | SNN0031 | - | - | - | - | 1件: 6 6 |
1871 | Sodium chloride | 2件: Chloride ion Chloride ion, Sodium chloride | 1件: D02056
D02056
| - | - | 21件: 6 6, 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 67, 78, 96, 168, 193, 227, 228, 271, 288, 299 |
1872 | Sodium Oxybate | 2件: Sodium oxybate Sodium oxybate, gamma-Hydroxybutyric acid | 1件: D05866
D05866
| - | - | 2件: 6 6, 149 |
1873 | Sodium phosphate enema, oral rifaximin and polyethylene glycol | 3件: Phosphate ion Phosphate ion, Polyethylene glycol, Rifaximin | 2件: D02554
D02554
,
D03370
| - | - | 1件: 6 6 |
1874 | Solifenacin | 1件: Solifenacin Solifenacin | 2件: D01269
D01269
,
D08522
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 3件: 6 6, 13, 53 |
1875 | Solifenacin Succinate (VESIcare) | 1件: Solifenacin Solifenacin | 2件: D01269
D01269
,
D08522
| 1件: CHRM3 CHRM3 💬 | 11件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction 💬 | 1件: 6 6 |
1876 | SOLIGEN | - | - | - | - | 1件: 6 6 |
1877 | Solu-Cortef | 2件: Hydrocortisone cypionate Hydrocortisone cypionate, Hydrocortisone succinate | 2件: D00976
D00976
,
D01442
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 6 6, 81, 83 |
1878 | Solu-Cortef, powder for solution for injection, 100mg, and 'Act-O-Vial' | 2件: Hydrocortisone Hydrocortisone, Hydrocortisone succinate | 2件: D00088
D00088
,
D01442
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1879 | Solution de chlorhydrate de dopamine anaérobie | 1件: Dopamine Dopamine | 2件: D00633
D00633
,
D07870
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1880 | Soluzione di levodopa/carbidopa | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1881 | Sorbitol | 1件: Sorbitol Sorbitol | 1件: D00096
D00096
| - | - | 2件: 6 6, 10 |
1882 | Soy protein | - | - | - | - | 2件: 6 6, 96 |
1883 | SPECT | - | - | - | - | 1件: 6 6 |
1884 | SPECT imaging | - | - | - | - | 1件: 6 6 |
1885 | Spheramine (BAY86-5280) | - | - | - | - | 1件: 6 6 |
1886 | Spiropent | - | - | - | - | 2件: 6 6, 13 |
1887 | SPM 926 | - | - | - | - | 1件: 6 6 |
1888 | SPM 962 | - | - | - | - | 1件: 6 6 |
1889 | SPM962 | - | - | - | - | 1件: 6 6 |
1890 | SpotOn balance glasses | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1891 | SQJZ herbal mixtures | - | - | - | - | 1件: 6 6 |
1892 | SR57667B | - | - | - | - | 1件: 6 6 |
1893 | Stalevo | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1894 | Stalevo (levodopa/ carbidopa/ entacapone) | 2件: Carbidopa Carbidopa, Entacapone | 2件: D00558
D00558
,
D00781
| 2件: COMT COMT, DDC 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1895 | Stalevo (levodopa/carbidopa/entacapona) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1896 | Stalevo (levodopa/carbidopa/entacapone) | 3件: Carbidopa Carbidopa, Entacapone, Levodopa | 3件: D00059
D00059
,
D00558
,
D00781
| 7件: COMT COMT, DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 17件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
1897 | Stalevo 100 | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1898 | Stalevo 100 mg/ 25 mg/ 200 mg Filmtabletten | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1899 | Stalevo 100 mg/25 mg / 200 mg | - | - | - | - | 1件: 6 6 |
1900 | Stalevo 100/25/200 mg | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1901 | Stalevo 150 | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1902 | Stalevo 150/37.5/200 mg | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
1903 | STALEVO*100CPR 100/25/200MG | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1904 | STALEVO*100CPR 50/12,5/200MG | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1905 | Stalevo® | - | - | - | - | 1件: 6 6 |
1906 | Standard LD/CD | - | - | - | - | 1件: 6 6 |
1907 | Standard of Care | - | - | - | - | 10件: 6 6, 13, 46, 49, 51, 63, 64, 79, 171, 271 |
1908 | Static, dynamic and functional balance exercises | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1909 | Static, dynamic and functional balance exercises with dual task | 1件: Isoxaflutole Isoxaflutole | - | - | - | 1件: 6 6 |
1910 | Stilnoct | - | - | - | - | 1件: 6 6 |
1911 | Stimulator OFF | - | - | - | - | 1件: 6 6 |
1912 | Stimulator ON | - | - | - | - | 1件: 6 6 |
1913 | Strattera | - | - | - | - | 1件: 6 6 |
1914 | Study Drug | - | - | - | - | 2件: 6 6, 13 |
1915 | Subcutaneous apomorphine | 1件: Apomorphine Apomorphine | 2件: D02004
D02004
,
D07460
| 2件: DRD1 DRD1, DRD2 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1916 | Subcutaneous hydrocortisone 10mg | 1件: Hydrocortisone Hydrocortisone | 1件: D00088
D00088
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 6 6 |
1917 | Subjects will undergo the 123-I IBVM imaging visit | - | - | - | - | 1件: 6 6 |
1918 | Sugar pill | - | - | - | - | 8件: 5 5, 6, 49, 67, 70, 86, 206, 210 |
1919 | Sulfate | 1件: Sulfate ion Sulfate ion | - | - | - | 27件: 2 2, 3, 6, 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 218, 222, 226, 265, 296, 297, 299 |
1920 | Sulforaphane | 1件: Sulforaphane Sulforaphane | - | - | - | 2件: 6 6, 205 |
1921 | Sumanirole | 1件: Sumanirole Sumanirole | - | - | - | 1件: 6 6 |
1922 | Supplementation | - | - | - | - | 1件: 6 6 |
1923 | Supressi. T-Diet plus Range | - | - | - | - | 1件: 6 6 |
1924 | Suvorexant | 1件: Suvorexant Suvorexant | 1件: D10082
D10082
| 2件: HCRTR1 HCRTR1, HCRTR2 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 3件: 5 5, 6, 13 |
1925 | SYN115 | - | - | - | - | 1件: 6 6 |
1926 | SYN115 Tablets, 60 mg | - | - | - | - | 1件: 6 6 |
1927 | SYN120 | - | - | - | - | 1件: 6 6 |
1928 | Synthetic Oxytocin | 1件: Oxytocin Oxytocin | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1929 | Syntocinon | 1件: Oxytocin Oxytocin | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 3件: 6 6, 127, 193 |
1930 | Syntocinon 40 IU/ml nasal spray | 1件: Oxytocin Oxytocin | 1件: D00089
D00089
| 1件: OXTR OXTR 💬 | 4件: Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1931 | Tacrolimus | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 34件: 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 286, 299 |
1932 | TACROLIMUS TABLETS | 1件: Tacrolimus Tacrolimus | 2件: D00107
D00107
,
D08556
| 5件: PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | 33件: Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1933 | Tadalafil | 1件: Tadalafil Tadalafil | 1件: D02008
D02008
| 1件: PDE5A PDE5A 💬 | 3件: Metabolic pathways Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬 | 7件: 6 6, 51, 75, 84, 86, 113, 210 |
1934 | TAK-071 | - | - | - | - | 1件: 6 6 |
1935 | Talampanel | 1件: Talampanel Talampanel | 1件: D02696
D02696
| 4件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4 💬 | 16件: Amphetamine addiction Amphetamine addiction, Amyotrophic lateral sclerosis, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 2件: 2 2, 6 |
1936 | Talineuren | - | - | - | - | 1件: 6 6 |
1937 | Targinact 10 mg/5 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate | - | - | - | 2件: 6 6, 226 |
1938 | Targinact 20 mg/10 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
1939 | Targinact 5 mg/2.5 mg prolonged-release tablets | 1件: Manganese citrate Manganese citrate | - | - | - | 1件: 6 6 |
1940 | Tasmar | 1件: Tolcapone Tolcapone | 1件: D00786
D00786
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 2件: 6 6, 28 |
1941 | TAVAPADON | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1942 | Tavapadon 0.25 mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1943 | Tavapadon 0.25mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1944 | Tavapadon 1mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1945 | Tavapadon 5 mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1946 | Tavapadon 5mg | 1件: Tavapadon Tavapadon | 1件: D11431
D11431
| 2件: DRD1 DRD1, DRD5 💬 | 10件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | 1件: 6 6 |
1947 | TCE | - | - | - | - | 1件: 6 6 |
1948 | TCH346 (dibenz[b,f]oxepin-10-ylmethyl-prop-2-ynyl-amine, hydrogen maleate salt) | 1件: Hydrogen Hydrogen | - | - | - | 1件: 6 6 |
1949 | TD-9855 | - | - | - | - | 2件: 6 6, 17 |
1950 | TECHNETIUM (99MTC) EXAMETAZIME | 1件: Exametazime Exametazime | 1件: D01109
D01109
| - | - | 1件: 6 6 |
1951 | Terazosin | 1件: Terazosin Terazosin | 2件: D00610
D00610
,
D08569
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1952 | Terazosin 5 MG | 1件: Terazosin Terazosin | 2件: D00610
D00610
,
D08569
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1953 | Terazosin therapy | 1件: Terazosin Terazosin | 2件: D00610
D00610
,
D08569
| 3件: ADRA1A ADRA1A, ADRA1B, ADRA1D 💬 | 7件: AMPK signaling pathway AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1954 | Tesofensine | 1件: Tesofensine Tesofensine | - | - | - | 2件: 6 6, 193 |
1955 | THN02 | - | - | - | - | 1件: 6 6 |
1956 | THN102 Dosage A | - | - | - | - | 1件: 6 6 |
1957 | THN102 Dosage B | - | - | - | - | 1件: 6 6 |
1958 | THN102 Dosage C | - | - | - | - | 1件: 6 6 |
1959 | Tigan | 1件: Trimethobenzamide Trimethobenzamide | 2件: D02733
D02733
,
D08643
| - | - | 1件: 6 6 |
1960 | Tigan® | 1件: Trimethobenzamide Trimethobenzamide | 2件: D02733
D02733
,
D08643
| - | - | 1件: 6 6 |
1961 | Tissue samplings | - | - | - | - | 1件: 6 6 |
1962 | TO | - | - | - | - | 1件: 6 6 |
1963 | Tocovid Suprabio (HOV-12020) | - | - | - | - | 1件: 6 6 |
1964 | Tolcapon | 1件: Tolcapone Tolcapone | 1件: D00786
D00786
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
1965 | TOLCAPONE | 1件: Tolcapone Tolcapone | 1件: D00786
D00786
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 3件: 6 6, 28, 127 |
1966 | Tolubuterol Hydrochloride | - | - | - | - | 1件: 6 6 |
1967 | TOPIRAMATE | 1件: Topiramate Topiramate | 1件: D00537
D00537
| 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 6件: 6 6, 97, 140, 144, 156, 193 |
1968 | Topiramate (drug) | 1件: Topiramate Topiramate | 1件: D00537
D00537
| 36件: CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 53件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1969 | TOZ | - | - | - | - | 1件: 6 6 |
1970 | TOZADENANT | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1971 | Tozadenant (SYN115) 120 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1972 | Tozadenant (SYN115) 180 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1973 | Tozadenant (SYN115) 240 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1974 | Tozadenant (SYN115) 60 mg BID | 1件: Tozadenant Tozadenant | 1件: D10174
D10174
| 1件: ADORA2A ADORA2A 💬 | 7件: Alcoholism Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 💬 | 1件: 6 6 |
1975 | Traditional Chinese Medicinal Mixture (composed of Roucongrong and adjuvant) | - | - | - | - | 1件: 6 6 |
1976 | Transdermal flumazenil (Added 4/2020) | 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
1977 | Transdermal nicotine | 1件: Nicotine Nicotine | 3件: D03365
D03365
,
D05156
,
D05157
| 16件: CHRNA1 CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG 💬 | 7件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases 💬 | 1件: 6 6 |
1978 | TRIGEL | - | - | - | - | 1件: 6 6 |
1979 | Trihexyphenidyl | 1件: Trihexyphenidyl Trihexyphenidyl | 2件: D00787
D00787
,
D08638
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 5 5, 6 |
1980 | Trimethobenzamide | 1件: Trimethobenzamide Trimethobenzamide | 2件: D02733
D02733
,
D08643
| - | - | 1件: 6 6 |
1981 | Trimethobenzamide Hydrochloride | 1件: Trimethobenzamide Trimethobenzamide | 2件: D02733
D02733
,
D08643
| - | - | 1件: 6 6 |
1982 | Trivastal | - | - | - | - | 1件: 6 6 |
1983 | Tropicamide | 1件: Tropicamide Tropicamide | 1件: D00397
D00397
| 5件: CHRM1 CHRM1, CHRM2, CHRM3, CHRM4, CHRM5 💬 | 13件: Alzheimer disease Alzheimer disease, Calcium signaling pathway, Cholinergic synapse, Gastric acid secretion, Insulin secretion, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Regulation of actin cytoskeleton, Salivary secretion, Taste transduction, cAMP signaling pathway 💬 | 2件: 6 6, 19 |
1984 | Tryptophan | 1件: Tryptophan Tryptophan | 1件: D00020
D00020
| - | - | 1件: 6 6 |
1985 | Tryptophan (TRP) depletion | 1件: Tryptophan Tryptophan | 1件: D00020
D00020
| - | - | 1件: 6 6 |
1986 | Tulobuterol | 1件: Tulobuterol Tulobuterol | 1件: D02151
D02151
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1987 | TULOBUTEROL HYDROCHLORIDE | 1件: Tulobuterol Tulobuterol | 1件: D02151
D02151
| 1件: ADRB2 ADRB2 💬 | 9件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
1988 | TVP-1012 | - | - | - | - | 1件: 6 6 |
1989 | TVP-1012 (1 mg/day) with levodopa | 1件: Levodopa Levodopa | 1件: D00059
D00059
| 5件: DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 11件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | 1件: 6 6 |
1990 | TVP-1012 0.5mg | - | - | - | - | 1件: 6 6 |
1991 | TVP-1012 1mg | - | - | - | - | 1件: 6 6 |
1992 | Tyramine | 1件: Tyramine Tyramine | - | - | - | 1件: 6 6 |
1993 | Tyrosine | 1件: Tyrosine Tyrosine | 1件: D00022
D00022
| - | - | 3件: 6 6, 86, 111 |
1994 | UB-312 | - | - | - | - | 1件: 6 6 |
1995 | Ubiquinol | 1件: Ubiquinol Ubiquinol | - | - | - | 3件: 6 6, 8, 17 |
1996 | UCB0022 | - | - | - | - | 1件: 6 6 |
1997 | UCB0599 | - | - | - | - | 1件: 6 6 |
1998 | UCB7853 | - | - | - | - | 1件: 6 6 |
1999 | Umbilical cord blood therapy | 1件: Umbilical Cord Blood Hematopoietic Stem Cells Umbilical Cord Blood Hematopoietic Stem Cells | - | - | - | 2件: 2 2, 6 |
2000 | Urate | 1件: Uric acid Uric acid | - | - | - | 1件: 6 6 |
2001 | Ursodeoxycholic acid | 1件: Ursodeoxycholic acid Ursodeoxycholic acid | 1件: D00734
D00734
| 1件: NR1H4 NR1H4 💬 | 1件: Bile secretion Bile secretion 💬 | 9件: 6 6, 46, 67, 84, 93, 94, 95, 96, 97 |
2002 | Ursonorm | - | - | - | - | 1件: 6 6 |
2003 | Usual dopaminergic per os treatment | - | - | - | - | 1件: 6 6 |
2004 | V1512 | - | - | - | - | 1件: 6 6 |
2005 | V1512 and Entacapone | 1件: Entacapone Entacapone | 1件: D00781
D00781
| 1件: COMT COMT 💬 | 4件: Dopaminergic synapse Dopaminergic synapse, Metabolic pathways, Steroid hormone biosynthesis, Tyrosine metabolism 💬 | 1件: 6 6 |
2006 | V81444 | - | - | - | - | 1件: 6 6 |
2007 | Valerian | 1件: Valerian Valerian | - | - | - | 1件: 6 6 |
2008 | Valiloxybate | - | - | - | - | 1件: 6 6 |
2009 | VARENICLINE | 1件: Varenicline Varenicline | 1件: D08669
D08669
| 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 2件: 6 6, 18 |
2010 | VARENICLINE TARTRATE | 1件: Varenicline Varenicline | 1件: D08669
D08669
| 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 1件: 6 6 |
2011 | Variation of behaviors of Parkinson's disease | - | - | - | - | 1件: 6 6 |
2012 | Vehicle | - | - | - | - | 4件: 6 6, 36, 160, 192 |
2013 | Venglustat | 1件: Venglustat Venglustat | 1件: D11633
D11633
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 6 6, 19, 67 |
2014 | Venglustat GZ/SAR402671 | 1件: Venglustat Venglustat | 1件: D11633
D11633
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 2件: 6 6, 67 |
2015 | Venglustat malate | 1件: Venglustat Venglustat | 1件: D11633
D11633
| 1件: UGCG UGCG 💬 | 2件: Metabolic pathways Metabolic pathways, Sphingolipid metabolism 💬 | 3件: 6 6, 19, 67 |
2016 | Venlafaxine | 1件: Venlafaxine Venlafaxine | 2件: D00821
D00821
,
D08670
| 2件: SLC6A2 SLC6A2, SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 3件: 6 6, 13, 46 |
2017 | ViNeuro | - | - | - | - | 1件: 6 6 |
2018 | Vitamin B12 | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 4件: 6 6, 201, 229, 299 |
2019 | Vitamin B12 Supplementation | 1件: Cyanocobalamin Cyanocobalamin | 4件: D00166
D00166
,
D03615
,
D03616
,
D03617
| - | - | 1件: 6 6 |
2020 | Vitamin B6 | 1件: Pyridoxine Pyridoxine | 2件: D02179
D02179
,
D08454
| - | - | 2件: 6 6, 206 |
2021 | Vitamin D3 | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 12件: 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 |
2022 | Vitamin D3 - high dose | 1件: Cholecalciferol Cholecalciferol | 1件: D00188
D00188
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 1件: 6 6 |
2023 | Vitamin E | 1件: Vitamin E Vitamin E | 1件: D02331
D02331
| - | - | 11件: 2 2, 6, 13, 20, 46, 90, 96, 97, 206, 299, 317 |
2024 | VIUSID/ALZER | - | - | - | - | 1件: 6 6 |
2025 | Vortioxetine | 1件: Vortioxetine Vortioxetine | 1件: D10184
D10184
| 7件: HTR1A HTR1A, HTR3A, HTR3B, HTR3C, HTR3D, HTR3E, SLC6A4 💬 | 5件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
2026 | VR040 | - | - | - | - | 1件: 6 6 |
2027 | VR040/Aspirair® inhaler | - | - | - | - | 1件: 6 6 |
2028 | VY-AADC01 | - | - | - | - | 1件: 6 6 |
2029 | VY-AADC02 | - | - | - | - | 1件: 6 6 |
2030 | Warfarin | 1件: Warfarin Warfarin | 3件: D00564
D00564
,
D01280
,
D08682
| 2件: NQO1 NQO1, VKORC1 💬 | 7件: Biosynthesis of cofactors Biosynthesis of cofactors, Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis 💬 | 13件: 6 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 |
2031 | Water | 1件: Water Water | 1件: D00001
D00001
| - | - | 23件: 2 2, 5, 6, 13, 17, 19, 22, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 |
2032 | WD-1603 | - | - | - | - | 1件: 6 6 |
2033 | WD-1603 CARBIDOPA and LEVODOPA EXTENDED-RELEASE TABLETS | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
2034 | WD-1603 Carbidopa-Levodopa Extended-Release Tablets | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
2035 | WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS | 2件: Carbidopa Carbidopa, Levodopa | 2件: D00059
D00059
,
D00558
| 6件: DDC DDC, DRD1, DRD2, DRD3, DRD4, DRD5 💬 | 16件: Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬 | 1件: 6 6 |
2036 | Weancare-domus | - | - | - | - | 1件: 6 6 |
2037 | Wheat | 1件: Wheat Wheat | 1件: D06902
D06902
| - | - | 3件: 6 6, 98, 266 |
2038 | Wheat bran | 2件: Wheat Wheat, Wheat bran | 1件: D06902
D06902
| - | - | 1件: 6 6 |
2039 | Whey protein | - | - | - | - | 2件: 6 6, 96 |
2040 | White chocolate (0% cocoa) | 1件: Cocoa Cocoa | - | - | - | 1件: 6 6 |
2041 | WIN-1001X | - | - | - | - | 1件: 6 6 |
2042 | Wuling Powder | - | - | - | - | 1件: 6 6 |
2043 | Xadago | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 2件: 6 6, 17 |
2044 | XADAGO (safinamide) | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
2045 | XADAGO - 100 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
2046 | XADAGO - 50 MG- COMPRESSA RIVESTITA CON FILM- USO ORALE- BLISTER (PVC/PVDC/ALLUMINIO)- 30 COMPRESSE | 1件: Safinamide Safinamide | 1件: D10158
D10158
| 1件: MAOB MAOB 💬 | 14件: Alcoholism Alcoholism, Amphetamine addiction, Arginine and proline metabolism, Cocaine addiction, Dopaminergic synapse, Drug metabolism - cytochrome P450, Glycine, serine and threonine metabolism, Histidine metabolism, Metabolic pathways, Parkinson disease, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
2047 | XC130-A10H | - | - | - | - | 1件: 6 6 |
2048 | Xeomin | 1件: Botulinum toxin type A Botulinum toxin type A | 1件: D00783
D00783
| 1件: SNAP25 SNAP25 💬 | 2件: Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | 7件: 5 5, 6, 7, 13, 15, 17, 113 |
2049 | Xiaoyao Pill | - | - | - | - | 1件: 6 6 |
2050 | XP21279 | - | - | - | - | 1件: 6 6 |
2051 | XP21279 and carbidopa (experimental) | 1件: Carbidopa Carbidopa | 1件: D00558
D00558
| 1件: DDC DDC 💬 | 9件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | 1件: 6 6 |
2052 | Yohimbine | 1件: Yohimbine Yohimbine | 1件: D08685
D08685
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
2053 | Yohimbine HCl | 1件: Yohimbine Yohimbine | 1件: D08685
D08685
| 3件: ADRA2A ADRA2A, ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 1件: 6 6 |
2054 | Zelapar | - | - | - | - | 1件: 6 6 |
2055 | Zoledronic acid | 1件: Zoledronic acid Zoledronic acid | 4件: D01968
D01968
,
D06378
,
D06379
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 12件: 5 5, 6, 13, 17, 46, 93, 95, 96, 270, 274, 299, 333 |
2056 | Zoledronic Acid 5Mg/Bag 100Ml Inj | 1件: Zoledronic acid Zoledronic acid | 4件: D01968
D01968
,
D06378
,
D06379
,
D08689
| 1件: FDPS FDPS 💬 | 4件: Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 3件: 5 5, 6, 17 |
2057 | Zolmitriptan | 1件: Zolmitriptan Zolmitriptan | 1件: D00415
D00415
| 2件: HTR1B HTR1B, HTR1D 💬 | 4件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | 1件: 6 6 |
2058 | Zolpidem | 1件: Zolpidem Zolpidem | 2件: D00706
D00706
,
D08690
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 3件: 5 5, 6, 46 |
2059 | Zolpidem first dose | 1件: Zolpidem Zolpidem | 2件: D00706
D00706
,
D08690
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
2060 | Zolpidem second dose | 1件: Zolpidem Zolpidem | 2件: D00706
D00706
,
D08690
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
2061 | Zolpidem Tartrate | 1件: Zolpidem Zolpidem | 2件: D00706
D00706
,
D08690
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |
2062 | Zonegran | 1件: Zonisamide Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 1件: 6 6 |
2063 | Zonisamide | 1件: Zonisamide Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 1件: 6 6 |
2064 | Zonisamide Capsules | 1件: Zonisamide Zonisamide | 1件: D00538
D00538
| 8件: CACNA1G CACNA1G, CACNA1H, CACNA1I, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | 11件: Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dopaminergic synapse, GnRH secretion, MAPK signaling pathway, Taste transduction, Type II diabetes mellitus 💬 | 1件: 6 6 |
2065 | Zopiclone | 1件: Zopiclone Zopiclone | 1件: D01372
D01372
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 1件: 6 6 |